Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
   volgende >>
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             1764 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Aβ40 And Aβ42 Levels In Dog Cerebrospinal Fluid de Rivera, Christina
2009
5 4S p. e10
artikel
2 Aβ1-42 and Aβ25-35 peptides induce similar toxicity in organotypic hippocampal slice cultures and this effect can be prevented by resveratrol Frozza, Rudimar L.
2009
5 4S p. P175
artikel
3 A BBB-permeable antioxidant targeting Alzheimer's amyloidogenesis Huang, Xudong
2009
5 4S p. P429
artikel
4 ABCA1 is required for the beneficial effects of the liver-X-receptor agonist GW3965 on biochemical and cognitive outcomes in the APP/PS1 mouse model of Alzheimer's disease Donkin, James
2009
5 4S p. P428
artikel
5 Aberrant adult neurogenesis in transgenic mice expressing APP intracellular domain Pimplikar, Sanjay W.
2009
5 4S p. P483
artikel
6 Aberrant localization of amyloid precursor protein in X11 and X11L- deficient mice brain Saito, Yuhki
2009
5 4S p. P173-P174
artikel
7 Abeta 42-1 correlates with learning potential as measured by a plasticity-based test approach Uttner, Ingo
2009
5 4S p. P448
artikel
8 A-beta enhance the ATBF1 expression responsible for the neuronal cell death Jung, Cha-Gyun
2009
5 4S p. P309
artikel
9 Abeta-oligomer selective antibody A-887755 exhibits a favorable profile for Alzheimer's disease immunotherapy compared to Abeta-peptide unselective antibodies Barghorn, Stefan
2009
5 4S p. P424
artikel
10 Abeta42-to-abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme Zou, Kun
2009
5 4S p. P224
artikel
11 Abeta42 trimer DNA vaccination is effective and safe as potential therapy for early Alzheimer's disease Lambracht-Washington, Doris
2009
5 4S p. P414
artikel
12 Abnormal mitochondrial structural and functional changes caused by amyloid beta in Alzheimer's disease Mao, Peizhong
2009
5 4S p. P152
artikel
13 Abnormal motor symptoms of Alzheimer's disease are associated with regional volume loss in frontal lobes and cerebellar hemispheres: A Voxel-Based Morphometric study Kim, Hee-Jin
2009
5 4S p. P15-P16
artikel
14 Abnormal motor symptoms of Alzheimer's disease are associated with regional volume loss in frontal lobes and cerebellar hemispheres; A voxel-based morphometric study Kim, Hee-Jin
2009
5 4S p. P195
artikel
15 ABT-089, a neuronal nicotinic receptor partial agonist, reverses scopolamine-induced cognitive deficits in healthy normal subjects Baker, Jeffrey D.
2009
5 4S p. P325
artikel
16 ABT-089 demonstrates efficacy in a human model of cognition and good tolerability in subjects with Alzheimer's disease taking acetylcholinesterase inhibitors Lenz, Robert A.
2009
5 4S p. P157
artikel
17 A case report of Alzheimer disease with presenilin-1 mutation (Met233Leu) showing a new phenotype Takaya, Masahiko
2009
5 4S p. P183
artikel
18 A case report of Alzheimer's disease with presenilin-1 mutation (Met233Leu) showing a new phenotype Takaya, Masahiko
2009
5 4S p. P10
artikel
19 Accumulation of Abeta oligomers in Alzheimer's disease is associated with cognitive impairment by disrupting scaffold dendritic spine proteins: Effects of immunotherapy Pham, Hang M.
2009
5 4S p. P498-P499
artikel
20 Accumulation of microtubule-associated protein in striated neurites is induced by mitochondrial dysfunction Goldsbury, Claire
2009
5 4S p. P313
artikel
21 Accuracy of reported family history and effectiveness of medical record requests in genetic counseling for Alzheimer's disease Butler, Rachel K.
2009
5 4S p. P459-P460
artikel
22 A clinical trial of docosahexanoic acid (DHA) for the treatment of Alzheimer's disease Quinn, Joseph F.
2009
5 4S p. P84
artikel
23 A comparative study of the efficacy with escitalopram and tianeptine in older depressed patients with or without executive dysfunction Kwak, Kyung-Phil
2009
5 4S p. P500
artikel
24 A comparison of Neuropsychological Test Battery (NTB) and ADAS-cog performance in an Alzheimer's disease clinical trial Black, Ronald S.
2009
5 4S p. P457
artikel
25 Actions of apoE and ABC transporters on APP processing Garner, Brett
2009
5 4S p. P168
artikel
26 Actions of apoE and cholesterol in abeta metabolism Zerbinatti, Celina
2009
5 4S p. P167
artikel
27 Activated astrocytes may contribute to lower levels of soluble and aggregated β-amyloid in insulin-degrading enzyme knockout/APP transgenic mice Guénette, Suzanne Y.
2009
5 4S p. P177-P178
artikel
28 Activated astrocytes suppress amyloid plaque pathogenesis in APP/PS1 mice Kraft, Andrew W.
2009
5 4S p. P154
artikel
29 Activated PKR levels correlates with PACT levels in the brains of AD patients and in APP/PS1 KI transgenic mice Paquet, Claire
2009
5 4S p. P311
artikel
30 Activation of MT2 receptor rescues Alzheimer-like axonopathy and promotes axon outgrowth Liu, Dan
2009
5 4S p. P490
artikel
31 Activity of phospholipase A2 (PLA2) subtypes in rat brain is altered by feeding conjugated linoleic acid (CLA) and linseed oil Nádia R. Barbosa,
2009
5 4S p. P326
artikel
32 Acute administration of a novel M1 receptor allosteric potentiator (BQCA) restores reversal learning in a transgenic mouse model of Alzheimer's disease (Tg2576) Nicolle, Michelle M.
2009
5 4S p. P424
artikel
33 Acute administration of CHF5074, a novel gamma-secretase modulator, improves contextual memory in a transgenic mouse model of Alzheimer's disease Imbimbo, Bruno P.
2009
5 4S p. P417-P418
artikel
34 Acute endotoxeimia as an initiator factor for brain inflammation: Implications for Alzheimer's disease Qasimov, Eldar
2009
5 4S p. P45
artikel
35 Acute endotoxeimia as an initiator factor for brain inflammation: Implications for Alzheimer's disease Qasimov, Eldar
2009
5 4S p. P482
artikel
36 Adapting scales for use in global clinical Alzheimer's disease trials Sugishita, Morihiro
2009
5 4S p. P170
artikel
37 A 10-day training program for persons with dementia and their carers: A practical nonpharmacological treatment program Stefanie, Auer R.
2009
5 4S p. P406
artikel
38 Added value of neurochemical biomarkers Hampel, Harald
2009
5 4S p. P99
artikel
39 Added Value of PET ligands Mathis, Chester A.
2009
5 4S p. P99
artikel
40 Aβ-dependent inhibition of LTP in different intra-cortical circuits of the visual cortex is mediated by RAGE Domenici, Luciano
2009
5 4S p. P499
artikel
41 A dietary pattern associated with reduced risk of Alzheimer's disease Gu, Yian
2009
5 4S p. P282
artikel
42 A Diffusion Tensor MRI study of patients with Mild cognitive impairment and Alzheimer's disease with a two-year clinical follow up Agosta, Federica
2009
5 4S p. P125-P126
artikel
43 A direct comparison of ventricular volumes derived from 1.5 Tesla and 3.0 Tesla MRI in 115 ADNI participants M. Nestor, Sean
2009
5 4S p. P264
artikel
44 A direct comparison of ventricular volumes derived from 1.5 Tesla and 3.0 Tesla MRI in 115 ADNI participants Nestor, Sean M.
2009
5 4S p. P50-P51
artikel
45 A disease progression meta-analysis model for cognitive deterioration in patients with Alzheimer's disease Ito, Kaori
2009
5 4S p. P255
artikel
46 ADNI PiB Studies Mathis, Chester A.
2009
5 4S p. P1
artikel
47 ADtect® - A novel blood test for the early detection of Alzheimer's disease Rye, Philip
2009
5 4S p. P278
artikel
48 Advantage of 3T in MRS studies of Alzheimer's disease and mild cognitive impairment Gordon, Marc L.
2009
5 4S p. P203
artikel
49 Advantage of 3T in MRS studies of Alzheimer's disease and mild cognitive impairment Gordon, Marc L.
2009
5 4S p. P32
artikel
50 A dynamical model for the development of the average neuron and synapse population densities in the human cerebral cortex from birth to six years de Figueiredo, Rui J.
2009
5 4S p. P59
artikel
51 A dynamical model for the development of the average neuron and synapse population densities in the human cerebral cortex from birth to six years de Figueiredo, Rui J.
2009
5 4S p. P220-P221
artikel
52 Aerobic-related physical activity interacting with Apolipoprotein E genotypes is associated with better cognitive function in a nationally representative sample: The Third National Health and Nutrition Examination Survey (NHANES III) Obisesan, Thomas O.
2009
5 4S p. P292-P293
artikel
53 Age and sociodemographic variables associated with cognitive performance in a biracial (black-white), young-to-middle age population: The Bogalusa Heart Study Gustat, Jeanette
2009
5 4S p. P387
artikel
54 Age, APOE genotype, gender and serial position effects in healthy adults Pomara, Nunzio
2009
5 4S p. P472
artikel
55 Age-dependent impairment of cognitive and synaptic function in transgenic mouse model of tau pathology (htau mouse) Polydoro, Manuela
2009
5 4S p. P153-P154
artikel
56 Age-related changes in number and expression patterns of cholinergic and GABAergic basal forebrain neurons in spatially characterized young and aged F344 rats LaSarge, Candi L.
2009
5 4S p. P177
artikel
57 Age-related decline in cognitive function is associated with cerebrospinal fluid concentration of brain-derived neurotrophic factor Peskind, Elaine R.
2009
5 4S p. P349-P350
artikel
58 Age-related dysfunction of insulin degrading enzyme (IDE) and insulin signaling pathway and the reversive effect of rosiglitazone Zhao, Qianhua
2009
5 4S p. P44
artikel
59 Age-related dysfunction of insulin degrading enzyme (IDE) and insulin signaling pathway and the reversive effect of rosiglitazone Zhao, Qianhua
2009
5 4S p. P473
artikel
60 Age-related impairments in tau transgenic mice using two different water maze training protocols Melis, Valeria
2009
5 4S p. P441-P442
artikel
61 Agitation and nursing home structure- how are they related?: A three country study Testad, Ingelin
2009
5 4S p. P245
artikel
62 A highly sensitive diagnostic assay for early diagnosis of Alzheimer's disease A. Funke, Susanne
2009
5 4S p. P273
artikel
63 AIBL (Australian Imaging, Biomarkers and Lifestyle) flagship study of aging Villemagne, Victor L.
2009
5 4S p. P1-P2
artikel
64 AIF and PARP-1, the molecular targets for Amyloid beta-toxicity: Alzheimer's disease genetic mutation increases cells susceptibility to nitrosative stress Strosznajder, Joanna B.
2009
5 4S p. e29
artikel
65 A 56kD SDS-stable peptide assembly is prominent among multiple oligomers in Alzheimer synapses Gylys, Karen H.
2009
5 4S p. P115-P116
artikel
66 A late expression of brain-derived neurotrophic factor is required for the synaptic remodeling in the persistence of fear memory Ou, Li-Chin
2009
5 4S p. P176
artikel
67 Algorithms to retrospectively diagnose mild cognitive impairment and dementia in a longitudinal study of aging and dementia Finelli, Luca
2009
5 4S p. P455-P456
artikel
68 ALOIS: Alzheimer's and cognitive improvement studies register, a free, on-line register of dementia and cognitive enhancement trials (http://www.medicine.ox.ac.uk/alois/) Malouf, Reem
2009
5 4S p. P251-P252
artikel
69 A low-dose of intravenous immunoglobulin provides protection in focal and global brain ischemia models and abolishes the increased ischemic vulnerability of aged APP/PS1 mice Heikkinen, Riikka
2009
5 4S p. P478
artikel
70 Alpha-synuclein oligomers alter excitatory synaptic transmission via both pre- and postsynaptic mechanisms Hüls, Sandra
2009
5 4S p. P495
artikel
71 Alpha-synuclein oligomers induce calcineurin-dependent neurotoxicity and memory deficits Taglialatela, Giulio
2009
5 4S p. P500
artikel
72 Alpha-synuclein regulates neurite outgrowth through the transcriptional regulation of Cdc42 Kim, Seonghan
2009
5 4S p. P486-P487
artikel
73 Alteration of protein kinase C in red blood cells: A potential marker for Alzheimer's disease de Barry, Jean
2009
5 4S p. P348
artikel
74 Alterations in activation between mild cognitive impaired subjects during a working memory task and resting coherent network Bokde, Arun
2009
5 4S p. P23
artikel
75 Alterations in activation between mild cognitive impaired subjects during a working memory task and resting coherent network Bokde, Arun
2009
5 4S p. P366
artikel
76 Alterations of brain glucose metabolism in aged APP/PS1 mice: An original voxel-based statistical analysis using BrainRAT and SPM Hérard, Anne-Sophie
2009
5 4S p. P9
artikel
77 Alterations of brain glucose metabolism in aged APP/PS1 mice: An original voxel-based statistical analysis using Brain RAT and SPM Hérard, Anne-Sophie
2009
5 4S p. P209
artikel
78 Altered amyloid metabolism in neuroinflammation Mattsson, Niklas
2009
5 4S p. P153
artikel
79 Altered hippocampal network activity links memory deficits and depressive symptoms in amnestic mild cognitive impairment Goveas, Joseph S.
2009
5 4S p. P47-P48
artikel
80 Altered hippocampal network activity links memory deficits and depressive symptoms in amnestic mild cognitive impairment Goveas, Joseph S.
2009
5 4S p. P214
artikel
81 Altered macromolecule signal in the hippocampus in Alzheimer patients measured by 1H magnetic resonance spectroscopy Bartha, Robert
2009
5 4S p. P51
artikel
82 Altered macromolecule signal in the hippocampus in alzheimer patients measured by 1H magnetic resonance spectroscopy Bartha, Robert
2009
5 4S p. P215-P216
artikel
83 ALZAS and ALZAS1, mechanistic biomarkers and targets for pre-symptomatic diagnosis in AD Bergmann, Johanna
2009
5 4S p. P351
artikel
84 Alzheimer and tauopathies Buee, Luc
2009
5 4S p. P171
artikel
85 Alzheimer disease's effects on blood pressure and cerebral perfusion are modified by cholinesterase inhibitors Claassen, Jurgen A.H.R.
2009
5 4S p. P206-P207
artikel
86 Alzheimer-like changes are found in male, but not female hypogonadal mice and appear exacerbated after injury Drummond, Eleanor
2009
5 4S p. P178-P179
artikel
87 Alzheimer patients’ caregivers survey in greece Margioti, Eleni
2009
5 4S p. P234
artikel
88 Alzheimer's Disease (AD) and Lewy bodies Dementia (LBD) differential diagnosis: a 123Ioflupane SPECT study Nuvoli, Susanna
2009
5 4S p. P17
artikel
89 Alzheimer's Disease (AD) and Lewy Bodies Dementia (LBD) differential diagnosis: A 123Ioflupane SPECT study Nuvoli, Susanna
2009
5 4S p. P195
artikel
90 Alzheimer'S disease (ad) and mild cognitive impairment (mci) patients are characterized by increased bdnf serum levels Angelucci, Francesco
2009
5 4S p. P272-P273
artikel
91 Alzheimer's disease and cancer: an independent association? Nobrega, Camila
2009
5 4S p. P295
artikel
92 Alzheimer's disease and how the community responses in developing country Joshi, Shambhu D.
2009
5 4S p. P232-P233
artikel
93 Alzheimer's disease and subcortical dementia may share similar patterns of cognitive deficits in the early stages Fukui, Toshiya
2009
5 4S p. P355
artikel
94 Alzheimer's disease genetics: Current status and future perspectives Bertram, Lars
2009
5 4S p. P147
artikel
95 Alzheimer's disease is inversely correlated with Cancer? Findings from a community-based sample from São Paulo, Brazil Bottino, Sara M.B.
2009
5 4S p. P292
artikel
96 Alzheimer's Patients Exhibit Defective Serum Ceruloplasmin Associated with Defective Copper Binding Brewer, George
2009
5 4S p. e23-e24
artikel
97 Alzhiemer's disease: Differentiation from other dementias based on quantitative diffusion tensor imaging on 3 Tesla MRI Kumari, Rima
2009
5 4S p. P198
artikel
98 A megalin polymorphism associated with increased Alzheimer's disease risk Vargas, Teo
2009
5 4S p. P281
artikel
99 A meta-analysis of computerized assessment batteries in Alzheimer's disease treatment trials Riordan, Henry J.
2009
5 4S p. P457-P458
artikel
100 A microanatomical correlate of cognitive decline in Mild cognitive impairment and Alzheimer's disease Chance, Steven A.
2009
5 4S p. P108
artikel
101 A model-based approach to understanding the natural history of cognitive change in treated and untreated Alzheimer's disease Corrigan, Brian
2009
5 4S p. P158-P159
artikel
102 A molecular mechanism by which I2PP2A cleavage leads to PP2A inhibition and tau hyperphosphorylation Arnaud, Lisette T.
2009
5 4S p. P475-P476
artikel
103 AMPA receptor activation promotes non-amyloidogenic processing of the amyloid precursor protein in neurones Hoey, Sarah E.
2009
5 4S p. P492
artikel
104 A multicenter, double-blind, placebo-controlled phase IIb proof-of-concept dose-ranging study of AZD3480 and donepezil over 12 weeks in patients with mild to moderate Alzheimer's disease Frölich, Lutz
2009
5 4S p. P85
artikel
105 A multigenerational family with inherited, pathologically confirmed Creutzfeldt-Jakob disease unexplained by PRNP van der Zee, Julie
2009
5 4S p. P164
artikel
106 Amyloid aggregated induces membrane perforations in oocytes from Xenopus laevis Parodi, Jorge
2009
5 4S p. P484
artikel
107 Amyloid aggregation induces membrane perforations in oocytes from Xenopus laevis Parodi, Jorge
2009
5 4S p. P46
artikel
108 Amyloid-β and its relevance to the detection of Alzheimer's disease in blood plasma: Findings from the first phase of the Australian Imaging, Biomarker and Lifestyle (AIBL) flagship study of ageing Lui, James
2009
5 4S p. P345-P346
artikel
109 Amyloid-beta (Aß) 42 prefibrillar oligomer-specific mimotope-peptide which inhibits Aß42 but not Aß40 fibril formation Tanaka, Koichi
2009
5 4S p. P421-P422
artikel
110 Amyloid beta: A putative intraspinal microtubule-depolymerizer to induce synapse loss or spinal shortening in Alzheimer's disease Mitsuyama, Fuyuki
2009
5 4S p. P405
artikel
111 Amyloid-beta dynamics in the injured human brain Brody, David L.
2009
5 4S p. P115
artikel
112 Amyloid beta induces changes in NMDA and AMPA receptor trafficking in primary neuronal cultures and brain slices Hirst, Warren D.
2009
5 4S p. P304
artikel
113 Amyloid beta oligomers at central synapses Inestrosa, Nibaldo C.
2009
5 4S p. P69
artikel
114 Amyloid-beta peptide is required for synaptic plasticity and memory Puzzo, Daniela
2009
5 4S p. P155
artikel
115 Amyloid Beta-peptide Length Strongly Affects Aggregation Kinetics Vandersteen, Annelies
2009
5 4S p. e15
artikel
116 Amyloid deposition and brain volume across the continuum of aging and Alzheimer's Disease Becker, John A.
2009
5 4S p. P126-P127
artikel
117 Amyloid deposition and instrumental activities of daily living impairment in non-demented elderly Marshall, Gad A.
2009
5 4S p. P215
artikel
118 Amyloid deposition and instrumental activities of daily living impairment in nondemented elderly Marshall, Gad A.
2009
5 4S p. P51
artikel
119 β-amyloid neurotoxicity in organotypic hippocampal slice culture is attenuated by melatonin: involvement of GSK-3β, tau and neuroinflammation Salbego, Christianne
2009
5 4S p. P481
artikel
120 Amyloidogenic metabolism of human APP in X11-like deficient mice brain Kondo, Maho
2009
5 4S p. P224
artikel
121 Amyloidosis and inflammation: Indications for a dual function of glutaminyl cylcase in Alzheimer's disease Cynis, Holger
2009
5 4S p. P75-P76
artikel
122 Amyloid plaques are formed in association with specific plasma membrane domains: An EM-immunogold 3-D-reconstruction study Nuntagij, Paworn
2009
5 4S p. P302
artikel
123 β-amyloid plaques in a PiB-PET negative subject: Implications for sensitivity of amyloid imaging in vivo Ikonomovic, Milos D.
2009
5 4S p. P30
artikel
124 β-amyloid plaques in a PiB-PET negative subject: Implications for sensitivity of amyloid imaging in vivo Ikonomovic, Milos D.
2009
5 4S p. P202
artikel
125 Amyloid Precursor Protein (APP) clusters at CNS nodes of Ranvier and causes an APPThr668 phosphorylation-dependent increase in Nav1.6 sodium channel currents Ma, Quanhong
2009
5 4S p. P486
artikel
126 Amyloid precursor protein plays an essential role in neuronal migration and commissural axon elongation in during zebrafish development Pimplikar, Sanjay W.
2009
5 4S p. P182
artikel
127 Amyloid seeds formed by cellular uptake, concentration, and aggergation of the Abeta1-42 peptide Lee, Jin-Moo
2009
5 4S p. P173
artikel
128 Analysis of Aβ and neuroinflammation as a function of brain region and disease progression in the TgCRND8 brain Ma, Keran
2009
5 4S p. P479
artikel
129 Analysis Of Adas-cog Constructional Praxis Scoring Errors McNamara, Cynthia
2009
5 4S p. e12
artikel
130 Analysis of ALS6 in frontotemporal lobar degeneration Pickering-Brown, Stuart M.
2009
5 4S p. P151
artikel
131 Analysis of an Aβ-like peptide in CSF to reveal whether and how the cleavage precision of presenilin/γ-secretase is altered in AD patients Tagami, Shinji
2009
5 4S p. P227
artikel
132 Analysis of EEG gamma band oscillations in progressive mild cognitive impairment indicates impaired activation of attention processes Gold, Gabriel
2009
5 4S p. P361
artikel
133 Analysis of genetic variability in APOE and neighbouring genes in mild cognitive impairment Cervantes, Sebastián
2009
5 4S p. P463
artikel
134 Analysis of memory in an aging population: Interaction of hippocampal structure and function Reitz, Christiane
2009
5 4S p. P367
artikel
135 Analysis of memory in an aging population: Interaction of hippocampal structure and function Reitz, Christiane
2009
5 4S p. P24
artikel
136 Analysis of the dimerization and metabolism of different APP isoforms Ben Khalifa, Naouel
2009
5 4S p. P303
artikel
137 Analysis of top-down control and spatial attention in mild cognitive impairment and Alzheimer's disease: Relationship to ApoE4 genotype Redel, Petra
2009
5 4S p. P452
artikel
138 Analysis of types and patterns of neuropsychological assessment in patients with mild cognitive impairment in Pusan Kyeong-Nam province: Multicenter observation study Park, Kyung Won
2009
5 4S p. P356-P357
artikel
139 Analyze Alzheimer's DNA microarray gene expression data by using pattern recognition methods Kong, Wei
2009
5 4S p. P279-P280
artikel
140 An Angiotensin-Converting Enzyme (ACE) polymorphism is associated with intracerebral hemorrhage recurrences in Cerebral Amyloid Angiopathy patients Guillamon, Mar Hernandez
2009
5 4S p. P465
artikel
141 A naturalistic study of rivastigmine transdermal patch in outpatient services in Austria Schmidt, Reinhold
2009
5 4S p. P332
artikel
142 ANDI - tools and methods for amalgamating large neuroimaging databases Janke, Andrew L.
2009
5 4S p. P369
artikel
143 A new drug target for treating Alzheimer's disease (AD): Structural images and models of Abeta-42 channels and their blockade by small molecule drugs, synthetic peptides, and metal cations Guy, H. Robert
2009
5 4S p. P138
artikel
144 A new Functional Cognitive Index and its evaluation as a predictive factor of survival in elders D'Orsi, Eleonora
2009
5 4S p. P393
artikel
145 A new quantitative 99mTc HMPAO Brain SPECT analysis in Alzheimer's Disease (AD) and Lewy bodies Dementia (LBD) differential diagnosis Nuvoli, Susanna
2009
5 4S p. P49-P50
artikel
146 A new quantitative 99mTc HMPAO brain SPECT analysis in Alzheimer's Disease (AD) and Lewy bodies Dementia (LBD) differential diagnosis Nuvoli, Susanna
2009
5 4S p. P214-P215
artikel
147 An examination of previously reported Alzheimer candidate genes within a large genome-wide association dataset Gerrish, Amy
2009
5 4S p. P468
artikel
148 An exploratory analysis of variables associated with MCI evolution through data mining with novel artificial neural networks Montali, Arianna
2009
5 4S p. P456
artikel
149 Animal models for Alzheimer's disease and frontotemporal dementia Gotz, Jurgen
2009
5 4S p. P118
artikel
150 An investigation of behavioral effects of Huprine X, a new potent anticholinesterasic, compared with Huperzine-A in 3xTgAD mice Gimenez Llort, Lydia
2009
5 4S p. P246
artikel
151 An in vitro model of glia activation to dissect the specific roles of astrocytes and microglia in neurodegenerative diseases Consonni, Alessandra
2009
5 4S p. P480-P481
artikel
152 A novel PS1 mutation in a large aboriginal kindred with early onset familial Alzheimer's disease from a remote community in northern British Columbia Butler, Rachel
2009
5 4S p. P149-P150
artikel
153 A novel role of beta-secretase1 (BACE1) in the pathogenesis of Cerebral Amyloid Angiopathy (CAA) Cheng, Xin
2009
5 4S p. P151
artikel
154 A novel staging tool for determining disease severity in frontotemporal dementia patients Mioshi, Eneida
2009
5 4S p. P80
artikel
155 A novel transgenic rat model displaying the full Alzheimer-like amyloid pathology with early, preplaque-stage cognitive deficits Leon, Wanda C.
2009
5 4S p. P440
artikel
156 An RNAI screen for genes that modify human amyloid induced paralysis in caenorhabditis elegans facilitates functional analysis of candidate risk factors for Alzheimer's disease M. Moloney, Aileen
2009
5 4S p. P435
artikel
157 Antemortem functioning and pathologic relationships in the entorhinal cortex from mild cognitive impairment to most severe (fast stage 7f) alzheimer's disease: A comprehensive study Reisberg, Barry
2009
5 4S p. P273
artikel
158 Antemortem IL-6 levels associated with vascular pathology but not Alzheimer pathology in cases from the Einstein Aging Study Derby, Carol A.
2009
5 4S p. P481
artikel
159 Anti-amnestic and neuroprotective activities of ANAVEX2-73: A new aminotetrahydrofuran derivative acting as a mixed muscarinic/sigma-1 ligand, in pharmacological and pathological models of amnesia Villard, Vanessa
2009
5 4S p. P324
artikel
160 Antibodies in the dimer fraction of IVIG have the capacity to bind beta amyloid Relkin, Norman R.
2009
5 4S p. P427-P428
artikel
161 Antibody immune response in cynomolgus monkeys following treatment with the active Aß immunotherapy CAD106 Imbert, Georges
2009
5 4S p. P427
artikel
162 Antidepressant drug use and cognitive deficits in older men: addressing confounding by indication using different methods Han, Ling
2009
5 4S p. e7
artikel
163 An ultrasensitive method for the detection of aggregated Beta-amyloid Scrocchi, Louise A.
2009
5 4S p. P438-P439
artikel
164 A peripheral diagnostic for Alzheimer's disease with 100% specificity and 94% sensitivity in preliminary testing Coleman, Paul D.
2009
5 4S p. P10
artikel
165 A peripheral diagnostic for Alzheimer's disease with 100% specificity and 94% sensitivity in preliminary testing Coleman, Paul D.
2009
5 4S p. P350
artikel
166 ApoE and amyloid beta deflate the cholinergic neurotransmission by boosting the activity and stability of cholinesterases in the brain Darreh-Shori, Taher
2009
5 4S p. P305
artikel
167 APOE and quality of life in the oldest old Lapid, Maria I.
2009
5 4S p. P236
artikel
168 Apoeϵ3 A3nd Tomm-40 Haplotypes Determine Inheritance of Alzheimer's Disease Independently of Apoeϵ4 Risk Roses, Allen D.
2009
5 4S p. e1
artikel
169 APOE E4 affects spatial working memory and attention in patients with amnestic mild cognitive impairment Laczó, Jan
2009
5 4S p. P357
artikel
170 ApoE genotype and amyloid beta effects on cognition are mediated by cell injury (tau) and death (progressive atrophy) DeCarli, Charles
2009
5 4S p. P110
artikel
171 Apoe4 may contribute to cholesterol retention in Alzheimer brain Zhang, Wandong
2009
5 4S p. P306-P307
artikel
172 Apolipoprotein E and Butyrylcholinesterase synergistically promote Ab peptides oligomerization Darreh-Shori, Taher
2009
5 4S p. P225
artikel
173 Apolipoprotein E as a therapeutic target for Alzheimer's disease Mahley, Robert W.
2009
5 4S p. P165
artikel
174 Apolipoprotein E fragmentation in human brain and CSF samples is isoform and Alzheimer's disease dependent Xu, Qin
2009
5 4S p. P307-P308
artikel
175 Apolipoprotein E4 impairs mitochondrial function and increases reactive oxygen species in neuronal cells Brodbeck, Jens
2009
5 4S p. P307
artikel
176 Apolipoprotein E4-induced mitochondrial dysfunction depends on its structure and can be rescued by a structure corrector Chen, Hung-Kai
2009
5 4S p. P307
artikel
177 Apoptosis is a defensive mechanism against the probable damages of chronic inflammation induced by Aβ in hippocampus in male rats Abdi, Azadeh
2009
5 4S p. P45
artikel
178 Apoptosis is a defensive mechanism against the probable damages of chronic inflammation induced by Aβ in hippocampus in male rats Abdi, Azadeh
2009
5 4S p. P479
artikel
179 APP and BACE1 miRNA genetic variability in risk for Alzheimer's disease Bettens, Karolien
2009
5 4S p. P149
artikel
180 Applicability study of the Adelaide Activities Profile in a sample of active Japanese older adults and descendents residents in São Paulo, Brazil Kanashiro, Miriam M.
2009
5 4S p. P240-P241
artikel
181 Application of AD-8 to screen very mild dementia in Taiwan Liu, Ching-Kuan
2009
5 4S p. P186
artikel
182 APP-mediated increase of L-type calcium currents leads to inhibition of calcium oscillations in a neuronal network Santos, Susana Ferrao
2009
5 4S p. P487
artikel
183 APP modulates synapse formation and function Herms, Jochen
2009
5 4S p. P69
artikel
184 A preliminary study of GEPT capsule in the treatment of amnestic mild cognitive impairment Tian, Jinzhou
2009
5 4S p. P255
artikel
185 A preliminary study of hippocampal subfield atrophy using the ADNI dataset Das, Sandhitsu R.
2009
5 4S p. P101-P102
artikel
186 A randomised study to compare the efficacy, tolerability and safety between Memantine and Donepezil in moderate to severe Alzheimer's disease Haridas, Kiran M.
2009
5 4S p. P320
artikel
187 Are there specific neuropsychiatric symptoms of depression in dementia patients? Prado-Jean, Annie
2009
5 4S p. P274
artikel
188 Are we adequately evaluating and monitoring rater performance in clinical trails with dementia? Gaur, Richa
2009
5 4S p. P240
artikel
189 Art Therapy For Demented Elderly: A Pilot Study Mak, Benise
2009
5 4S p. e25
artikel
190 A safe, potent, selective brain penetrant and orally active 5-HT6 receptor antagonist SUVN-502 Nirogi, Ramakrishna
2009
5 4S p. P337-P338
artikel
191 A safety, tolerability and pharmacokinetic study of dimebon in patients with Alzheimer's disease already receiving donepezil Tariot, Pierre
2009
5 4S p. P251
artikel
192 Ascertaining older african americans for genetic studies in Alzheimer's disease Byrd, Goldie S.
2009
5 4S p. P234
artikel
193 A sensitive assay measuring the binding of amyloid-beta monomers to aggregates reveals the potential of ELND005 (scylloinositol) to reduce and reverse amyloid accumulation Pastrak, Aleksandra
2009
5 4S p. P415
artikel
194 A short form of MMSE (7 categories) and a short form of CDR (Memory category only) can classify subjects into normal, MCI subjects and mild Alzheimer's Sugishita, Morihiro
2009
5 4S p. P450
artikel
195 A short form of the Literacy Independent Cognitive Assessment (LICA-S): development and cross-validation Kim, Jung Eun
2009
5 4S p. e31
artikel
196 Aβ-specific Th1 cells exacerbate plaque formation and induce memory impairments in APPswe/pS1dE9 mice McQuillan, Keith
2009
5 4S p. P323
artikel
197 Assessing outcome measures for prodromal AD clinical trials: A retrospective analysis from the ADNI database Feldman, Howard H.
2009
5 4S p. P363
artikel
198 Assessing productive behaviour in daily life of patients diagnosed with dementia. Contribution of the revised Functional Behaviour Profile (FBP) Ochs, Julien
2009
5 4S p. P230
artikel
199 Assessing quality of life by EQ-5D among Chinese elderly with cognitive function impairment: Findings from SCOBHI pilot Ding, Ding
2009
5 4S p. P237-P238
artikel
200 Assessing SUVR metrics for different PET cameras in amyloid imaging Buckley, Chris J.
2009
5 4S p. P51-P52
artikel
201 Assessing the impact of Alzheimer's disease: Attitudes and behaviours across Europe Jones, Roy W.
2009
5 4S p. P89
artikel
202 Assessment of life style of elderly women with Alzheimer's disease living in nursing home Wlodarek, Dariusz
2009
5 4S p. P237
artikel
203 Assessment of structural differences in normal aging and Alzheimer's disease: Quantitative and qualitative differences using subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) Nikelski, Jim
2009
5 4S p. P219
artikel
204 Assessment of structural differences in normal aging and Alzheimer's disease: Quantitative and qualitative differences using subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) Nikelski, Jim
2009
5 4S p. P58
artikel
205 Association between CSF phosphorylated tau and risk factors of Alzheimer's disease Ewers, Michael
2009
5 4S p. P93
artikel
206 Association between insulin resistance and cognitive function in mild cognitive impairment Park, Hyun-Young
2009
5 4S p. P289
artikel
207 Association of a missense cathepsin D (CTSD) SNP with risk of Alzheimer's disease Burgess, Jeremy
2009
5 4S p. P469
artikel
208 Association of antipsychotic drug use and mortality in the very old with dementia: The monzino 80-plus study Pasina, Luca
2009
5 4S p. P336
artikel
209 Association of diabetes and blood glucose concentration with dementia in the very old: The Monzino 80-Plus Study Riva, Emma
2009
5 4S p. P283-P284
artikel
210 Association of global cognitive dysfunction with serum lipid levels among Korean elderly with mild cognitive impairment Kim, Young-Hoon
2009
5 4S p. P288-P289
artikel
211 Association of hippocampus head diffusivity and episodic memory performance in early Alzheimer's disease Fellgiebel, Andreas
2009
5 4S p. P50
artikel
212 Association of hippocampus head diffusivity and episodic memory performance in early Alzheimer's disease Fellgiebel, Andreas
2009
5 4S p. P263-P264
artikel
213 Association of metabolic dysregulation with volumetric brain mri and cognitive markers of subclinical brain aging in middle-aged adults: The Framingham Offspring study Tan, Zaldy S.
2009
5 4S p. P106
artikel
214 Association of MRI markers of vascular brain injury with mild cognitive impairment, incident stroke and mortality: The Framingham Offspring Study Debette, Stephanie
2009
5 4S p. P128
artikel
215 Association of neurotoxic Aβ-species and hippocampal cell loss with behavioral changes in TBA1 transgenic mice Alexandru, Anca
2009
5 4S p. P435
artikel
216 Association of plasma Aβ with risk of dementia: The prospective 3C-study Lambert, Jean-Charles
2009
5 4S p. P133
artikel
217 Association of sensory deficits with dementia in the very old: The Monzino 80-plus Study Tettamanti, Mauro
2009
5 4S p. P285
artikel
218 Association of vascular risk factors to the cognitive impairment in the community dwelling Korean elderly Ryu, Seung-Ho
2009
5 4S p. P287
artikel
219 Association of white matter hyperintensities on brain MRI to vascular and neurodegenerative risk factors Appel, Jason
2009
5 4S p. P394
artikel
220 Associations between baseline concentration of Alzheimer's disease biochemical markers and MRI regional rates of brain tissue loss in ADNI data Tosun, Duygu
2009
5 4S p. P78-P79
artikel
221 Association study about genetic variants of inflammation-linked genes and dementia in the very old: The Monzino 80-plus Study Albani, Diego
2009
5 4S p. P462
artikel
222 Association study of the ADAM12 and SH3MD1 genes with the risk of developing Alzheimer's disease Laumet, Geoffroy
2009
5 4S p. P462-P463
artikel
223 Astrin, a substrate of GSK3β is differentially expressed in AD compared to age-matched controls Bajic, Vladan P.
2009
5 4S p. P311
artikel
224 Astrocytes preferentially degrade apoE4: Impact on Aβ levels and neuronal plasticity in apoE targeted replacement mice Riddell, David
2009
5 4S p. P109-P110
artikel
225 A study on the association of the chromosome 12p13 locus with sporadic late-onset Alzheimer's disease in Chinese Song, You-Qiang
2009
5 4S p. P461
artikel
226 A tensor based morphometry study of patients with cognitive impairment and dementia in parkinson's disease Lu, Po H.
2009
5 4S p. P221
artikel
227 A tensor-based morphometry study of patients with cognitive impairment and dementia in Parkinson's disease Lu, Po H.
2009
5 4S p. P60
artikel
228 A ten year follow-up of hippocampal volume on MRI in early dementia and cognitive decline den Heijer, Tom
2009
5 4S p. P125
artikel
229 ATP-binding cassette transporter A7 inhibits amyloid-beta production in vitro Chan, Sharon Lai Ling
2009
5 4S p. P173
artikel
230 A traditional medicinal herb Paeonia suffruticosa and its active constituent 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose have potent anti-aggregation effects on Alzheimer's amyloid β proteins in vitro and in vivo Arai, Hiroyuki
2009
5 4S p. P418
artikel
231 A transgenic mouse model of amyloid β oligomers: Pathological effects of the E693Δ mutation in amyloid precursor protein in vivo Tomiyama, Takami
2009
5 4S p. P116-P117
artikel
232 Atrophy of nucleus lentiformis and thalamus in both Alzheimer's disease and vascular dementia: The Honolulu-Asia Aging Study de Jong, Laura W.
2009
5 4S p. P61
artikel
233 Atrophy of nucleus lentiformis and thalamus in both Alzheimer's disease and vascular dementia: The Honolulu-Asia aging study de Jong, Laura W.
2009
5 4S p. P503-P504
artikel
234 Attempt to identify novel presenilin-like proteases affecting canonical Wnt signaling Nakayama, Taisuke
2009
5 4S p. P227
artikel
235 Author Index 2009
5 4S p. P507-P542
artikel
236 Automated classification of periventricular and subcortical white matter lesions on MRI Verhaaren, Benjamin F.J.
2009
5 4S p. P293-P294
artikel
237 Automated classification of periventricular and subcortical white matter lesions on MRI Verhaaren, Benjamin F.J.
2009
5 4S p. P38
artikel
238 Automated hippocampal atrophy rates in subjects with and without cognitive impairment Barnes, Josephine
2009
5 4S p. P28
artikel
239 Automated hippocampal atrophy rates in subjects with and without cognitive impairment Barnes, Josephine
2009
5 4S p. P370
artikel
240 Aβ vaccination induces modifications of neuronal activated PKR staining in the brains of patients with Alzheimer's Disease (AD) Paquet, Claire
2009
5 4S p. P309
artikel
241 Aβ variability and effect of gamma secretase inhibition on cerebrospinal fluid levels of Aβ in healthy volunteers Soares, Holly
2009
5 4S p. P252-P253
artikel
242 A very short form of the German IQ CODE with a two-year observation period retains high diagnostic accuracy in MCI and early AD Ehrensperger, Michael M.
2009
5 4S p. P188
artikel
243 AZD4694: Fluorinated Positron Emission Tomography (PET) radioligand for detection of β-amyloid deposits Sundgren-Andersson, Anna K.
2009
5 4S p. P267-P268
artikel
244 AZD4694: Fluorinated Positron Emission Tomography (PET) radioligand for detection of β-amyloid deposits Sundgren-Andersson, Anna K.
2009
5 4S p. P57
artikel
245 BACE1 and BACE2 expression in primary cultures of neurons and astrocytes Bettegazzi, Barbara
2009
5 4S p. P476
artikel
246 Bace Inhibitors for the Treatment of Alzheimer's Disease Fälting, Johanna
2009
5 4S p. e5-e6
artikel
247 BACE1 is not the rate-limiting enzyme in Aβ production in the brains of APPswe transgenic mice: Pharmacological characterization of BACE1 using novel brain penetrant inhibitors. Riddell, D.R.
2009
5 4S p. P430
artikel
248 B-Amyloid treatment does not enhance the age-related increase in phagocytic activity of microglial cells O'Reilly, Julie-Ann
2009
5 4S p. P225-P226
artikel
249 Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: Results from ADNI Davatzikos, Christos
2009
5 4S p. P365
artikel
250 Baseline and longitudinal patterns of brain atrophy in MCI patients and their use in prediction of short-term conversion to Alzheimer's disease: Results from ADNI Davatzikos, Christos
2009
5 4S p. P21-P22
artikel
251 Baseline semantic fluency scores predict ChEI response as restoration of normal brain activity in patients with Alzheimer's disease McGeown, William J.
2009
5 4S p. P206
artikel
252 Baseline semantic fluency scores predict ChEI response as restoration of normal brain activity in patients with Alzheimer's disease McGeown, William J.
2009
5 4S p. P39
artikel
253 Bayesian network analysis reveals altered regional connectivity of the default mode network in Alzheimer's disease Fleisher, Adam
2009
5 4S p. P48
artikel
254 Bayesian Network analysis reveals altered regional connectivity of the default mode network in Alzheimer's disease Fleisher, Adam
2009
5 4S p. P261
artikel
255 BBS-1 - A novel inhibitor of the β-secretase pathway of Aβ generation in Alzheimer's disease Solomon, Beka
2009
5 4S p. P139
artikel
256 BDNF downregulation in post mortem brain tissue of subjects with tauopathies Fahnestock, Margaret
2009
5 4S p. P398-P399
artikel
257 BDNF prevents activation of stress related kinases by Aβ in cortical neurons Bonadonna, Camilla
2009
5 4S p. P495
artikel
258 Behavioral characterization of a new transgenic mouse model of pGlu-Aβ induced neurotoxicity: Automated, high-resolution, intra-home-cage and ethological-based phenotyping Baeuscher, Christoph
2009
5 4S p. P436
artikel
259 Behavioral disturbances in early familial Alzheimer's disease Flores, Deborah L.
2009
5 4S p. P193
artikel
260 Behavioral performance of aged wild type and APPSWE2576 mice fed with LMN diet Escorihuela, Rosa M.
2009
5 4S p. P245-P246
artikel
261 Behavioral phenotyping of a new transgenic mouse model of pGlu-Aβ induced neurotoxicity: Classical behavioral approach Kohlmann, Stephanie
2009
5 4S p. P435-P436
artikel
262 Behavioural variant frontotemporal dementia: Limited sensitivity of current clinical diagnostic criteria Piguet, Olivier
2009
5 4S p. P80
artikel
263 Berberine can reduce calyculin A-induced tau hyperphosphorylation by inhibiting GSK-3β in HEK293/tau cell Yu, Guang
2009
5 4S p. P434
artikel
264 Beta-amyloid deposition is related to default mode network connectivity in normal controls Mormino, Elizabeth C.
2009
5 4S p. P100
artikel
265 Beta-secretase as target for amyloid-reduction therapy Tang, Jordan J.N.
2009
5 4S p. P74
artikel
266 Bias correction for linear simplifications of tracer kinetics with application in fibrillar amyloid beta measurements Guo, Hongbin
2009
5 4S p. P260
artikel
267 Bias correction for linear simplifications of tracer kinetics with application in fibrillar amyloid beta measurements Guo, Hongbin
2009
5 4S p. P46-P47
artikel
268 Binding form of curcumin derivatives to β-amyloid aggregates Yanagisawa, Daijiro
2009
5 4S p. P342-P343
artikel
269 Binding of a beta-amyloid 1-42 peptide to human albumin grifols® Costa, Montserrat
2009
5 4S p. P417
artikel
270 Biochemical biomarkers as endpoints in clinical trials: Applications in Phase 1, 2 and 3 studies Siemers, Eric
2009
5 4S p. P95
artikel
271 Biochemical characterization of FTLD-TDP overexpression and knockout mouse models Wils, Hans
2009
5 4S p. P154
artikel
272 Biomarker Based Diagnosis Of Very Mild Alzheimer'S Disease: A Multicenter Study Ewers, Michael
2009
5 4S p. e28
artikel
273 Biomarker discovery of Alzheimer-related peptides in serum of presymptomatic patients IJsselstijn, Linda
2009
5 4S p. P344
artikel
274 Biomarker screening for Alzheimer's Disease: When to screen and how often? Kahle-Wrobleski, Kristin
2009
5 4S p. P274
artikel
275 Biomarker screening for Alzheimer's disease: When to screen and how often? Kahle-Wrobleski, Kristin
2009
5 4S p. P15
artikel
276 Biomedicalization of cognitive deficits: Lessons from the Maracaibo Aging Study and implications for developing countries Maestre, Gladys E.
2009
5 4S p. P91
artikel
277 Biophysical characterization of scyllo-inositol-Aβ interactions McLaurin, JoAnne
2009
5 4S p. P427
artikel
278 Blood and CSF-based neurochemical dementia diagnostics: Current status and perspectives Wiltfang, Jens
2009
5 4S p. P148
artikel
279 Blood-based microcirculation markers in Alzheimer's disease: Diagnostic value of CT-proET-1 in patients with amnestic mild cognitive impairment Schneider, Philine
2009
5 4S p. P361
artikel
280 Blood Borne Aβ Dimer Correlates With Clinical Markers of Alzheimer's Disease Barnham, Kevin J.
2009
5 4S p. e2
artikel
281 Blood folate and beta-carotene are associated with asymptomatic Alzheimer's disease: The Nun Study Gross, Myron
2009
5 4S p. P129-P130
artikel
282 Blood pressure, apoe genotype, and dementia: The swedish brain power project Qiu, Chengxuan
2009
5 4S p. P129
artikel
283 Body mass index and dementia over 37 years in Sweden Gustafson, Deborah R.
2009
5 4S p. P128
artikel
284 Brain atrophy patterns in late-onset depression and mild cognitive impairment Zhang, Na
2009
5 4S p. P24
artikel
285 Brain atrophy patterns in late-onset depression and mild cognitive impairment Zhang, Na
2009
5 4S p. P367
artikel
286 Brain changes in 676 ADNI subjects: Summary of 10 studies using tensor based morphometry and automated hippocampal mapping Thompson, Paul
2009
5 4S p. P36-P37
artikel
287 Brain changes in 676 ADNI subjects: summary of 10 studies using tensor based-morphometry and automated hippocampal mapping Thompson, Paul
2009
5 4S p. P205
artikel
288 Brain-derived neurotrophic factor serum level is reduced in mild cognitive impairment and Alzheimer's disease Diniz, Breno S.
2009
5 4S p. P341
artikel
289 Brain imaging in diabetes mellitus: Metabolic or vascular damage? Biessels, Geert-Jan
2009
5 4S p. P123
artikel
290 Brain imaging in the presymptomatic detection, tracking and prevention of Alzheimer's disease Reiman, Eric M.
2009
5 4S p. P72
artikel
291 Brain methobolic changes in mild cognitive impairment and early Alzheimer's disease patients Ekinci, Gunseli
2009
5 4S p. P216
artikel
292 Brain microvascular fragility is a major cause of Alzheimer's disease Kirsch, Wolff M.
2009
5 4S p. P77-P78
artikel
293 Brain Perfusion SPECT in patients with Mild Cognitive Impairment: comparison with visual function assessment Lemos, Raquel
2009
5 4S p. e30
artikel
294 Breaking protein-protein interactions: A combined chemical and computational approach to develop a new class of protein aggregation inhibitors Graef, Isabella
2009
5 4S p. P429-P430
artikel
295 Burden among caregivers in lewy body dementia Leggett, Amanda N.
2009
5 4S p. P231
artikel
296 Calcium binding protein Secretagogin expression in wild type and transgenic tau (P301L) mice Attems, Johannes
2009
5 4S p. P155
artikel
297 Calcium dysregulation in Alzheimer's disease Bacskai, Brian J.
2009
5 4S p. P142
artikel
298 Calpain and calpain-activated caspase-8 in amyloid-b-peptide toxicity: Attenuation by calpastatin overexpression Kosower, Nechama S.
2009
5 4S p. P477
artikel
299 Canadians’ willingness to pay for Alzheimer's disease medications: Preliminary results of a study of the general public Oremus, Mark
2009
5 4S p. P241
artikel
300 Can cognitive training prevent the onset of dementia? A systematic review of randomized clinical trials with longitudinal follow up Valenzuela, Michael
2009
5 4S p. P157-P158
artikel
301 Can hippocampal or temporal horn atrophy rates predict future conversion to Alzheimer's disease? Macdonald, Kate
2009
5 4S p. P18-P19
artikel
302 Canonical Wnt signalling regulation of APP processing Parr, Callum J.C.
2009
5 4S p. P494
artikel
303 Cardiac function is related to maladaptive brain aging in mild cognitive impairment: Preliminary results Jefferson, Angela L.
2009
5 4S p. P363-P364
artikel
304 Cardiovascular autonomic dysfunction in dementia Choi, Seong H.
2009
5 4S p. P277
artikel
305 Caregiver differences in response to a psychobehavioral intervention for caregivers of alzheimer's disease patients: highlights from reach ii Czaja, Sara J.
2009
5 4S p. P228
artikel
306 Carnosine inhibits ß-sheet formation of PrP106-126 and protects against its neurotoxicity Kawahara, Masahiro
2009
5 4S p. P300
artikel
307 Carvedilol as a Potential Novel Disease Modifying Agent for the Treatment of Alzheimer's Disease Pasinetti, Giulio
2009
5 4S p. e27-e28
artikel
308 Carvedilol reduces Aβ oligomerization and improves spatial memory in mouse models of Alzheimer's disease Wang, Jun
2009
5 4S p. P427
artikel
309 Caspase-4 as a key factor in Alzheimer pathology Buxbaum, Joseph D.
2009
5 4S p. P483
artikel
310 Cathepsin D knockout mice harbor large and highly selective increases in cerebral Aß42 and tau: Implications for Alzheimer's disease pathogenesis Leissring, Malcolm A.
2009
5 4S p. P155-P156
artikel
311 CD200Fc fusion protein alleviates beta amyloid-induced glial-activation and neurodegeneration in vitro and in vivo Cowley, Thelma R.
2009
5 4S p. P480
artikel
312 CDK11/pitslre protein kinase is differentially expressed in hippocampus of Alzheimer patients Bajic, Vladan P.
2009
5 4S p. P311
artikel
313 Cell-based ciliary neurotrophic factor therapy against Alzheimer's disease Garcia, Pierre
2009
5 4S p. P330
artikel
314 Cell cycle and neurodegeneration in fly Feany, Mel B.
2009
5 4S p. P171
artikel
315 Cell cycle mediated neurodegeneration Lee, Hyoung-gon
2009
5 4S p. P171
artikel
316 Cell cycle Re-Entry and DNA replication in Alzheimer's disease Arendt, Thomas
2009
5 4S p. P171
artikel
317 Cell division in CNS Herrup, Karl
2009
5 4S p. P171
artikel
318 Cellular and animal model Lundja, Jacques O.
2009
5 4S p. P172
artikel
319 Cellular and animal model Lundja, Jacques O.
2009
5 4S p. P6
artikel
320 Cellular mechanisms underlying aberrant EEG activity and cognitive deficits in mouse models of Alzheimer's disease Reinhart, Peter
2009
5 4S p. P178
artikel
321 Ceramic hydroxyapatite-based phosphoprotein/peptide enrichment facilitates biochemical study of tau Liu, Ning
2009
5 4S p. P488-P489
artikel
322 Cerebral blood flow, white matter lesions and risk of hippocampal atrophy: The SMART-MR study Geerlings, Mirjam I.
2009
5 4S p. P389
artikel
323 Cerebral vascular encephalopathy causes decreased cerebrospinal Aβ concentrations Verbeek, Marcel M.
2009
5 4S p. P134
artikel
324 Cerebral ventricular subvolume analysis from MRI: A marker of Alzheimer’s disease progression validated using ADNI Nestor, Sean M.
2009
5 4S p. P371
artikel
325 Cerebral ventricular subvolume analysis from MRI: A marker of Alzheimer's disease progression validated using ADNI Nestor, Sean M.
2009
5 4S p. P32
artikel
326 Cerebrolysin in vascular dementia: a randomized, placebo controlled study Novak, Philipp H.
2009
5 4S p. P249
artikel
327 Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders Spies, Petra
2009
5 4S p. P342
artikel
328 Cerebrospinal fluid amyloid beta40 and the amyloid beta42/40 ratio in differentiating Alzheimer's disease from other dementias Spies, Petra
2009
5 4S p. P341-P342
artikel
329 Cerebrospinal fluid concentrations of functionally important amino acids in patients with Alzheimer’s disease compared to mild cognitive impairment Kaiser, Elmar
2009
5 4S p. P344
artikel
330 Cerebrospinal fluid norepinephrine is inversely related to aspects of cognition in normal aging Raskind, Murray A.
2009
5 4S p. P350
artikel
331 Cerebrovascular and memory deficits in an Alzheimer's disease mouse model overexpressing amyloid precursor protein and transforming growth factor-β1 Ongali, Brice
2009
5 4S p. P444
artikel
332 Challenging tests of memory are more sensitive to detect effects of amyloid deposition in normal elderly subjects Frey, Meghan T.
2009
5 4S p. P456
artikel
333 Challenging tests of memory are more sensitive to detect effects of amyloid deposition in normal elderly subjects Frey, Meghan T.
2009
5 4S p. P14
artikel
334 Change in third ventricle cross-sectional area reflects atrophy over 6 months in Alzheimer's disease Paskavitz, James F.
2009
5 4S p. P52
artikel
335 Change in third ventricle cross-sectional area reflects atrophy over 6 months in Alzheimer's disease F. Paskavitz, James
2009
5 4S p. P265-P266
artikel
336 Changes in cognition in relation to frailty in older Canadians Mitnitski, Arnold B.
2009
5 4S p. P391
artikel
337 Changes in cognition over eight years in elderly Japanese Americans: A multistate transition modeling approach Mitnitski, Arnold B.
2009
5 4S p. P390-P391
artikel
338 Changes in cortical thickness in asymptomatic individuals at genetic risk for Alzheimer's disease Bassett, Susan S.
2009
5 4S p. P204
artikel
339 Changes in cortical thickness in asymptomatic individuals at genetic risk for Alzheimer's disease Bassett, Susan S.
2009
5 4S p. P33
artikel
340 Changes In Erythrocyte Deformability In Alzheimer's Disease: A Role For Nitric Oxide Synthase Misiti, Francesco
2009
5 4S p. e12
artikel
341 Changes of brain network connectivity in early Alzheimer's disease: Preliminary findings applying a data-driven approach Song, Xiaowei
2009
5 4S p. P30
artikel
342 Characteristic patterns of cortical thickness in pathologically-confirmed Alzheimer's disease and frontotemporal lobar degeneration Lehmann, Manja
2009
5 4S p. P162-P163
artikel
343 Characteristics of delusions in Alzheimer's dementia patients Chung, Chan-Seung
2009
5 4S p. P191
artikel
344 Characterization of Alzheimer pathology by magnetoencephalography and the synchronous neural interaction test Verdoorn, Todd A.
2009
5 4S p. P48
artikel
345 Characterization of Alzheimer's pathology by magnetoencephalography and the synchronous neural interaction test Verdoorn, Todd A.
2009
5 4S p. P260-P261
artikel
346 Characterization of a mAb against human α-synuclein Mougenot, Anne-Laure
2009
5 4S p. P277
artikel
347 Characterization of inositol transporters as a method for drug delivery to the CNS Fenili, Daniela
2009
5 4S p. P326
artikel
348 Characterization of microglia derived from bone marrow hematopoietic stem cells: In vitro model for amyloid-beta toxicity and phagocytosis Magga, Johanna
2009
5 4S p. P480
artikel
349 Characterization of nonsynonymous changes in progranulin Bennion, Janis M.
2009
5 4S p. P487
artikel
350 Characterization of the pharmacokinetics, pharmacodynamics, and distribution of anti-abeta antibody MABT5102A Mortensen, Deborah
2009
5 4S p. P419
artikel
351 Characterization of transthyretin isoforms in CSF from patients with Alzheimer's disease and controls by high resolution mass spectrometry Poulsen, Keld
2009
5 4S p. P347
artikel
352 Chemical manipulation of Hsp70 activity regulates tau processing Dickey, Chad A.
2009
5 4S p. P319
artikel
353 CHF5074, a new g-secretase modulator, stimulates neurotrophin expression in primary neurons Del Giudice, Elda
2009
5 4S p. P425
artikel
354 CHF5074 reduces brain β-amyloid burden and hyperphosphorylated tau in a mouse model of Alzheimer's disease Pizzi, M.
2009
5 4S p. P422
artikel
355 Chinese perspectives on assessment, treatment and family roles Huang, Yueqin
2009
5 4S p. P118-P119
artikel
356 Cholesterol accumulation in NPC fibroblasts does not lead to lipid raft compartmentalization of APP and C99 Kosicek, Marko
2009
5 4S p. P225
artikel
357 Cholesterol in amyloid plaques: Analysis by laser capture microdissection combined with mass spectrometry Panchal, Maï
2009
5 4S p. P110-P111
artikel
358 Cholesterol in mild cognitive impairment and Alzheimer's disease in a prospective population-based study in Germany Schröder, Johannes
2009
5 4S p. P386
artikel
359 Cholinergic impairment in Parkinson Plus Syndrome: A molecular imaging study Mazere, Joachim
2009
5 4S p. P489
artikel
360 Cholinesterase inhibitors for Alzheimer's disease: Do they provide more than symptomatic benefits? Suh, Guk-Hee
2009
5 4S p. P336
artikel
361 Chronic cerebral hypoperfusion causes myelin damage and is associated with a selective impairment in working memory Horsburgh, Karen
2009
5 4S p. P318
artikel
362 Chronic kidney disease and cognitive function in older adults: The CRIC cognitive study Yaffe, Kristine
2009
5 4S p. P378
artikel
363 Circulating immune complexes of Aβ and IgM in plasma of patients with Alzheimer's disease Marcello, Andrea
2009
5 4S p. e32
artikel
364 Citalopram compared to atypical antipsychotics for Alzheimer patients who did not previously benefit from treatment: The catie-AD study Schneider, Lon S.
2009
5 4S p. P156
artikel
365 Citomorphologic and biochemical analysis of the CSF and oral mucosa in Alzheimer's disease: Potential diagnostic application Starling, Daniela
2009
5 4S p. P347-P348
artikel
366 Classification models for early identification of persons at risk for dementia Van Den Kommer, Tessa N.
2009
5 4S p. P381
artikel
367 Clinical and neurobehavioural features of frontotemporal dementias: A hospital-based study from South India Ellajosyula, Ratnavalli
2009
5 4S p. P506
artikel
368 Clinical and neuropsychological risk factors to conversion from mild cognitive impairment to Alzheimer disease Armas, Julio
2009
5 4S p. P382
artikel
369 Clinical correlates of caregiver burden in alzheimer's disease Mohamed, Somaia
2009
5 4S p. P228
artikel
370 Clinical different stage of Alzheimer's disease associated with amyloid load by [11C] PiB-PET imaging Hatashita, Shizuo
2009
5 4S p. P63
artikel
371 Clinical different stage of Alzheimer's disease associated with amyloid load by [11C] PIB-PET imaging Hatashita, Shizuo
2009
5 4S p. P270-P271
artikel
372 Clinical factors related to the size of carotid arterial plaque in stroke patients with dementia Lee, Jun Hong
2009
5 4S p. P187
artikel
373 Clinical Imaging Biomarkers In Alzheimer'S Disease Drug Development Grachev, Igor
2009
5 4S p. e25
artikel
374 Clinically significant depressive symptoms and associated factors in a community sample of elderly subjects Ferreira, Ricardo Barcelos
2009
5 4S p. P294-P295
artikel
375 Clinical phenotype of Alzheimer's disease caused by presenilin 1 mutations in Spain Gómez-Tortosa, Estrella
2009
5 4S p. P467-P468
artikel
376 Clinical Practices Regarding Mild Cognitive Impairment (MCI) Among Neurology Service Providers Roberts, Scott
2009
5 4S p. e4-e5
artikel
377 Clinical presentations of patients attending a dementia clinic in Kingston, Jamaica Barnaby, Loraine A.
2009
5 4S p. P11
artikel
378 Clinical presentations of patients attending a dementia clinic in Kingston, Jamaica Barnaby, Loraine A.
2009
5 4S p. P194
artikel
379 Clinical profile of Alzheimer's Disease (AD)-A study from North India Kushwaha, Suman
2009
5 4S p. P186
artikel
380 Clinical trials of EHT 0202, a neuroprotective and procognitive alpha-secretase stimulator for Alzheimer's disease Desire, Laurent
2009
5 4S p. P255-P256
artikel
381 Clinicopathologic correlations from the Nun study SantaCruz, Karen S.
2009
5 4S p. P109
artikel
382 Clustering Alzheimer MRI data using independent component analysis Yang, Wenlu
2009
5 4S p. P26
artikel
383 Clusterin is a Plasma Biomarker of Severity, Progression and Pathology in Alzheimer's Disease Thambisetty, Madhav
2009
5 4S p. e1
artikel
384 Co-expression of insulin signaling-related proteins and choline acetyltransferase in hippocampus neurons Wang, Rong
2009
5 4S p. P494-P495
artikel
385 Cognitive and clinical outcomes in a pilot study using a handheld computer game for cognitive training of patients with Mild Cognitive Impairment (MCI) Hsiung, Ging-Yuek R.
2009
5 4S p. P411
artikel
386 Cognitive and pathological benefits of Aβ-sensitive Th2 cells are independent of Antigen-Specific B cell activation Ethell, Douglas W.
2009
5 4S p. P420
artikel
387 Cognitive-behavioral psychotherapy for early Alzheimer's disease Werheid, Katja
2009
5 4S p. P406-P407
artikel
388 Cognitive correlations of stroke, white matter disease and brain atrophy after stroke: Preliminary validation of NINDS-VCI Harmonization criteria Black, Sandra E.
2009
5 4S p. P53-P54
artikel
389 Cognitive correlations of stroke, white matter disease and brain atrophy after stroke: Preliminary validation of NINDS-VCI harmonization criteria E. Black, Sandra
2009
5 4S p. P266
artikel
390 Cognitive deficits and plaque deposition in a gene-targeted mouse model of Alzheimer's disease Ciallella, John
2009
5 4S p. P181
artikel
391 Cognitive Effects Of Selective 5-ht4 Receptor Activation, In Rat Model Of Alzheimer's Disease Marchetti, Evelyne
2009
5 4S p. e30
artikel
392 Cognitive event related potentials as functional biomarkers in Alzheimer's disease W. Kilborn, Kerry
2009
5 4S p. P264-P265
artikel
393 Cognitive function of first-episode late-onset depression among Chinese elderly Zhang, Na
2009
5 4S p. P81
artikel
394 Cognitive function of patients with partial anterior circulation infarct and amnestic mild cognitive impairment Zhang, Mei-Yan
2009
5 4S p. P375
artikel
395 Cognitive function of patients with partial anterior circulation infarct and amnestic mild cognitive impairment Zhang, Mei-Yan
2009
5 4S p. P13
artikel
396 Cognitive impact of treatment with anticholinergic properties in elderly patients consulting for memory complaint Fortin, Marie-Pierre
2009
5 4S p. P339
artikel
397 Cognitive impairment in elderly in the rural area of Western Mexico Arias-Merino, Elva Dolores
2009
5 4S p. P393-P394
artikel
398 Cognitive impairment in type 2 diabetic patients using metformin or sulfonylurea: A comparative study Saadatnia, Mohammad
2009
5 4S p. P390
artikel
399 Cognitive impairment screening in a southern Brazilian elderly outpatient sample Otilia Cerveira, Maria
2009
5 4S p. P274
artikel
400 Cognitive interference in mild cognitive impairment: Insights from a spatial stimulus-response consistency task Juncos-Rabadán, Onesimo
2009
5 4S p. P376
artikel
401 Cognitive leisure activity as a protective factor in a prospective ageing study in Germany Sattler, Christine
2009
5 4S p. P291
artikel
402 Cognitive performance characteristics of individuals with normal or pathological CSF and MRI biomarkers of Alzheimer's disease Moelter, Stephen T.
2009
5 4S p. P159
artikel
403 Cognitive reserve modifies the relationship of neuropsychological performance and amyloid deposition in normal elderly subjects Rentz, Dorene M.
2009
5 4S p. P131-P132
artikel
404 Cognitive training on elderly Japanese in Osaka: Major outcome (ADAS) from prospective, randomized, open, blinded-endpoint trial Noriyuki Hayashi,
2009
5 4S p. P407-P408
artikel
405 Cognitive training on elderly Japanese in Osaka: Subgroup analysis Morihara, Takashi
2009
5 4S p. P408
artikel
406 Combination of memantine and donepezil reverses cognitive deficits in transgenic mice with both amyloid-beta plaques and neurofibrillary tangles LaFerla, Frank M.
2009
5 4S p. e29
artikel
407 Combined CSF cytochrome C levels and N200 latency may predict conversion from MCI to AD Papaliagkas, Vasileios T.
2009
5 4S p. P349
artikel
408 Combined SNP and copy number variation haplotypes at the MAPT locus Sule, Norbert
2009
5 4S p. P471
artikel
409 Combined treatment with cerebrolysin and donepezil in mild to moderate alzheimer's disease: Results of a double-blind, randomized clinical trial Alvarez, Anton
2009
5 4S p. P248
artikel
410 Community Cognitive Screening: Do differences exist between self referred and family referred subjects? Kandiah, Nagaendran
2009
5 4S p. P289
artikel
411 Comparative efficacy of risperidone versus yi-gan san on behavioural and psychological symptoms of dementia Furuhashi, Yuko
2009
5 4S p. P235
artikel
412 Comparative study of sex hormone serum levels and CSF markers in patients with Alzheimer's disease Bahl, Justyna M.C.
2009
5 4S p. P346-P347
artikel
413 Comparing MRI and CSF biomarkers in Alzheimer's disease: Intergroup discrimination and predicting clinical change Vemuri, Prashanthi
2009
5 4S p. P352-P353
artikel
414 Comparing MRI and CSF biomarkers in Alzheimer's disease: Intergroup discrimination and predicting clinical change Vemuri, Prashanthi
2009
5 4S p. P34-P35
artikel
415 Comparing predictors of conversion: Data from the Alzheimer's Disease Neuroimaging Initiative Landau, Susan M.
2009
5 4S p. P125
artikel
416 Comparison between the story recall test and the words list learning test in patients with mild cognitive impairment and early-stage Alzheimer's disease Kim, Hyun J.
2009
5 4S p. P240
artikel
417 Comparison of adverse drug reactions with donepezil versus memantine: Analysis of the French pharmacovigilance database Babai, Samy
2009
5 4S p. P337
artikel
418 Comparison of anti-β-secretase cleavage site antibodies and their affect on amyloid-β Thomas, Rhian
2009
5 4S p. P424
artikel
419 Comparison of brazilian portuguese lexical production of Alzheimer's disease patients and healthy elderly subjects Alegria, Renné P.
2009
5 4S p. P232
artikel
420 Comparison of cognitive performance and depressive symptoms between high cardiovascular risk and healthy community elderly groups Costa, Amanda L.
2009
5 4S p. P282-P283
artikel
421 Comparison of highly selective and non-selective 5-HT6 receptor antagonists in in vitro and in vivo neurodegenerative models Tkachenko, Sergey
2009
5 4S p. P492
artikel
422 Comparison of Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18F-FDG) PET in patients with Alzheimer's disease, Mild Cognitive Impairment and healthy controls Devanand, Davangere P.
2009
5 4S p. P16-P17
artikel
423 Comparison of Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18F-FDG) PET in patients with Alzheimer's disease, mild cognitive impairment, and healthy controls Devanand, Davangere P.
2009
5 4S p. P194
artikel
424 Comparison of psychometric properties between the Behavior Rating Scale for Dementia (BRSD) and the Neuropsychiatric Inventory (NPI) Youn, Jong Chul
2009
5 4S p. P241
artikel
425 Complex program for improvement of early diagnosis, therapy and respite care of Alzheimer´s disease patients in Slovakia Koson, Peter
2009
5 4S p. P411-P412
artikel
426 Compliance, persistence, and outcomes in patients with Alzheimer's disease treated with oral cholinesterase inhibitors Mody-Patel, Nikita
2009
5 4S p. P327
artikel
427 Compound Screening In A Drosophila melanogaster Alzheimer's Disease Model Using A Behavioral Readout Mahoney, Matt B.
2009
5 4S p. e11-e12
artikel
428 Computer-based visuospatial and wayfindng assessment for mild dementia of the Alzheimer's type: Preliminary results of healthy control group Lange, Belinda S.
2009
5 4S p. P377
artikel
429 COMT polymorphism and seven-year change in cognitive function in a biracial sample of older adults: Findings from the health ABC study Fiocco, Alexandra J.
2009
5 4S p. P484
artikel
430 Concentration of donepezil to therapeutic response in Alzheimer's disease Yang, Yuan-Han
2009
5 4S p. P324
artikel
431 Concordance and discordance between regional reduction of cerebral blood flow and brain atrophy in frontotemporal dementia Shimizu, Soichiro
2009
5 4S p. P221
artikel
432 Concordance and discordance between regional reduction of cerebral blood flow and brain atrophy in frontotemporal dementia Shimizu, Soichiro
2009
5 4S p. P60
artikel
433 Concordant association of functional IDE variant with IDE mRNA, Aß, and Alzheimer's disease Belbin, Olivia
2009
5 4S p. P469-P470
artikel
434 Conducting Alzheimer's clinical trials in Europe: Insights from the regulatory perspective Broich, Karl
2009
5 4S p. P171
artikel
435 Conducting an Alzheimer's clinical trial in Russia Seely, Lynn
2009
5 4S p. P171
artikel
436 Conformationally altered p53: A potential predictive marker from mild cognitive impairment to Alzheimer's disease? Lanni, Cristina
2009
5 4S p. P356
artikel
437 Consistency of behavioral and neural changes after focused cognitive rehabilitation in patients with mild cognitive impairment Hampstead, Benjamin M.
2009
5 4S p. P65
artikel
438 Consistency of behavioral and neural changes after focused cognitive rehabilitation in patients with mild cognitive impairment Hampstead, Benjamin M.
2009
5 4S p. P246
artikel
439 Contents 2009
5 4S p. A3-A5
artikel
440 Conterclockwise rotation in rey complex figure after acute caudate infarction Shin, Joon Hyun
2009
5 4S p. P458-P459
artikel
441 Continuous and cyclic progesterone differentially affect estrogen regulation of Alzheimer-like pathology in female 3xTg-AD mice Carroll, Jenna C.
2009
5 4S p. P333
artikel
442 Contralateral FMRI activation increase during confrontation naming in dementia patients with left temporal lobe atrophy Frings, Lars
2009
5 4S p. P201
artikel
443 Contralateral fMRI activation increases during confrontation naming in dementia patients with left temporal lobe atrophy Frings, Lars
2009
5 4S p. P29
artikel
444 Contributions of rigid and elastic spatial transformation steps to analysis of Alzheimer-related metabolic changes using automated regional quantification of brain PET scans Siu, Erin
2009
5 4S p. P49
artikel
445 Contributions of rigid and elastic spatial transformation steps to analysis of Alzheimer-related metabolic changes using automated regional quantification of brain PET scans Siu, Erin
2009
5 4S p. P262
artikel
446 Controlling self-assembly as a novel paradigm for the treatment of amyloid disease Gazit, Ehud
2009
5 4S p. P74
artikel
447 Control of genes transcription involved in neuronal lipids metabolism by the amyloid precursor protein APP Pierrot, Nathalie
2009
5 4S p. P306
artikel
448 Controversies In Anticholinergic Medication Use And Cognitive Impairment Fox, Chris
2009
5 4S p. e19
artikel
449 Conversion of Mild Cognitive Impairment (MCI) to Alzheimer Disease (AD): Risk factors Luiza, Spiru
2009
5 4S p. P388
artikel
450 Coordinated evaluation of astrogliosis, microglial activation and proliferation in the Alzheimer hippocampus in relation to cognitive status and amyloid pathology Lucassen, Paul J.
2009
5 4S p. P312
artikel
451 Correlation between Alzheimer's disease, pre-diabetes and diabetes mellitus evaluated by quantitative magnetic resonance imaging Roriz-Filho, Jarbas S.
2009
5 4S p. P49
artikel
452 Correlation between Alzheimer's disease, pre-diabetes and diabetes mellitus evaluated by quantitative magnetic resonance imaging S. Roriz-Filho, Jarbas
2009
5 4S p. P261-P262
artikel
453 Correlation between 18F-GE-067 and 11C-PIB uptake in Alzheimer's disease and MCI Van Laere, Koen
2009
5 4S p. P50
artikel
454 Correlation between 18F-GE-067 and 11C-PIB uptake in Alzheimer's disease and MCI Van Laere, Koen
2009
5 4S p. P263
artikel
455 Correlation between medial temporal lobe atrophy in MRI and CSF markers in Alzheimer's disease (AD) De Souza, Leonardo C.
2009
5 4S p. P201
artikel
456 Correlation between white matter hyperintensities in MRI-FLAIR and 11C-PiB PET retention: A new potential for early identification of disease Raniga, Parnesh
2009
5 4S p. P212
artikel
457 Correlation between white matter hyperintensities in MRI-FLAIR and 11C-PiB PET retention. A new potential for early identification of disease Raniga, Parnesh
2009
5 4S p. P42
artikel
458 Correlation between white matter lesions progression and cognitive decline in patients with Alzheimer's disease, mixed dementia, vascular dementia and normal elderly persons in prospective study Sutovsky, Stanislav
2009
5 4S p. P196-P197
artikel
459 Correlation between white matter lesions progression and cognitive decline in patients with Alzheimer's disease, mixed dementia, vascular dementia and normal elderly persons in prospective study Sutovsky, Stanislav
2009
5 4S p. P19-P20
artikel
460 Correlation of CSF biomarkers with 1H-MRS metabolites of the medial temporal lobe in Alzheimer's Disease Jessen, Frank
2009
5 4S p. P126
artikel
461 Correlation of SMC and OCI in dementia screening in urban community: Yangcheon-gu in seoul Go, Seungah
2009
5 4S p. P453
artikel
462 Cortical control of swallowing in early Alzheimer's disease: A functional magnetic resonance imaging study Humbert, Ianessa
2009
5 4S p. P503
artikel
463 Cortical disconnection in Alzheimer's disease: Insights from diffusion tensor imaging Teipel, Stefan J.
2009
5 4S p. P78
artikel
464 Cortical thickness and voxel-based morphometry in posterior cortical atrophy Lehmann, Manja
2009
5 4S p. P63-P64
artikel
465 Cortical thickness and voxel-based morphometry in posterior cortical atrophy Lehmann, Manja
2009
5 4S p. P271-P272
artikel
466 Could driving changes be used as a tool for predicting development of dementia? Frank-Garcia, Ana
2009
5 4S p. P360
artikel
467 [11C]PiB in patients with amnestic and non-amnestic MCI Persad, Carol
2009
5 4S p. P204
artikel
468 11C-PiB PET and hippocampal volumes are complementary in distinguishing dementia with Lewy bodies and Alzheimer's disease Kantarci, Kejal
2009
5 4S p. P59-P60
artikel
469 11C-PIB-PET imaging and cognitive statement in Alzheimer’s disease, mild cognitive impairment and healthy aging: 1-1.5 Year follow-up Study Ataka, Suzuka
2009
5 4S p. P358
artikel
470 Creative ways to care: A training program on the use of therapeutic strategies for family carers who are living with people who have behavioural and psychological symptoms of dementia Creaser, Virginia A.
2009
5 4S p. P243-P244
artikel
471 Creutzfeldt-Jakob disease with amyotrophy and a new four-octapeptide repeat insertion of the prion protein gene Kovács, Tibor
2009
5 4S p. P505
artikel
472 Critical role of Abca1 in maintaining functional apoE and apoA-I and their impact on A-beta aggregation and clearance from brain Koldamova, Radosveta
2009
5 4S p. P308
artikel
473 Cross cultural perspectives on assessment and treatment of Alzheimer's disease with a focus on economic evaluation Wimo, Anders B.
2009
5 4S p. P118
artikel
474 Cross-sectional validation of a new instrument for the measurement of treatment response: The Clinical Meaningfulness in Alzheimer Disease Treatment (CLIMAT) scale Jacova, Claudia
2009
5 4S p. P184
artikel
475 Crossword puzzles delay onset of accelerated cognitive decline in preclinical dementia, contributing to cognitive reserve Hall, Charles B.
2009
5 4S p. P385
artikel
476 Crystal Structure Of The Amyloid Precursor Protein Intracellular Domain In Complex With Fe65-PTB2 Wild, Klemens
2009
5 4S p. e15-e16
artikel
477 Crystal structure of the amyloid precursor protein intracellular domain in complex with Fe65-PTB2 Wild, Klemens
2009
5 4S p. P496-P497
artikel
478 Crystal structure of the crossroad in APP transport and signaling: The Fe65-PTB1 domain Klug, Wilfried
2009
5 4S p. P493
artikel
479 CSF Abeta and Tau associations with 3-D hippocampal radial distance mapped in 282 ADNI subjects Apostolova, Liana G.
2009
5 4S p. P6
artikel
480 CSF biomarker levels in early and classic onset of Alzheimer's disease Stefanova, Elka
2009
5 4S p. P350-P351
artikel
481 CSF biomarkers as outcome measures in clinical trials Galasko, Douglas
2009
5 4S p. P95
artikel
482 CSF biomarkers in posterior cortical atrophy: Evidence for a variant of Alzheimer's disease Baumann, Thomas P.
2009
5 4S p. P504
artikel
483 CSF biomarkers of Alzheimer's disease: An algorithm for interpretation of neurochemical dementia diagnostics analysis Lewczuk, Piotr
2009
5 4S p. P347
artikel
484 CSF biomarkers predict cognitive decline in Alzheimer's disease Kester, Maartje I.
2009
5 4S p. P341
artikel
485 Culturally valid cognitive impairment assessment of American Indians Jervis, Lori
2009
5 4S p. P121-P122
artikel
486 Current Anticholinergic Medication Use And Cognitive Impairment In The Older Population: The Medical Research Council Cognitive Function and Ageing Study Richardson, Kathryn
2009
5 4S p. e13
artikel
487 Current drug target sites in clinical practice or clinical trial, extent of disease modification for Alzheimer's disease Ul Haq Subhani, Farhan
2009
5 4S p. P420
artikel
488 Cut-off scores in MMSE: A moving target? Morgado, Joana
2009
5 4S p. P455
artikel
489 Cytosolic β-amyloid deposition and supranuclear cataracts in lenses from people with down syndrome Moncaster, Juliet A.
2009
5 4S p. P501
artikel
490 Cytosolic PLA2 is involved in the early synaptic alterations induced by the amyloid-beta oligomers Luc Olivier, Jean
2009
5 4S p. P153
artikel
491 DASH diet adherence scores and cognitive decline and dementia among aging men and women: Cache County study of memory health and aging Wengreen, Heidi J.
2009
5 4S p. P128
artikel
492 Davunetide (AL-108): Targeting tangles Gozes, Illana
2009
5 4S p. P74
artikel
493 Deciphering the role of APP in synaptic regulation Zheng, Hui
2009
5 4S p. P68
artikel
494 Declines in cognitive and sensorimotor function in tg4510 mutant mouse Roof, Robin L.
2009
5 4S p. P433-P434
artikel
495 Declines of hippocampal metabotropic glutamate receptor in Alzheimer's disease Minuzzi, Luciano
2009
5 4S p. P56-P57
artikel
496 Declines of hippocampal metabotropic glutamate receptor in Alzheimer's disease Minuzzi, Luciano
2009
5 4S p. P267
artikel
497 Decreased brain connectivity in healthy children of Alzheimer patients: The role of APOE genotype and family history Antuono, Piero
2009
5 4S p. P40
artikel
498 Decreased brain connectivity in healthy children of Alzheimer patients: the role of APOE genotype and family history Antuono, Piero
2009
5 4S p. P210
artikel
499 Decreased expression of GGA1 and GGA3 adaptor proteins in Alzheimer's disease frontal cortex Evin, Genevieve
2009
5 4S p. P477-P478
artikel
500 Decreased G-CSF plasma levels in patients with early Alzheimer`s disease - contribution to a deficient hematopoietic brain support? Laske, Christoph
2009
5 4S p. P318
artikel
501 Decrease of the antioxidant defenses in 3xTg-AD triple-transgenic adult mice for Alzheimer's disease Gimenez-Llort, Lydia
2009
5 4S p. P502
artikel
502 Defining mild cognitive impairment: Disparity of incidence and prevalence estimates with variable operationalized definitions Ward, Alex
2009
5 4S p. P286
artikel
503 Degradation of truncated tau protein in transgenic rat cortical neurons and human cellular model of tauopathy and Alzheimer's disease is enhanced by HSP90 inhibitors Opattova, Alena
2009
5 4S p. P402-P403
artikel
504 Delayed motor learning and cerebellar electrophysiological alterations in a murine model of Alzheimer's disease with massive amyloidosis Hoxha, Eriola
2009
5 4S p. P434
artikel
505 Delta project: Delirium in hospitalized elderly Marie-Pierre Thibodeau,
2009
5 4S p. P273
artikel
506 Dementia differential: adding visual-semiquantitative evaluation to a quantitative method for reporting brain SPECT: Comparison between two institutions Staffen, Wolfgang
2009
5 4S p. P17-P18
artikel
507 Dementia in general practice Pond, Constance D.
2009
5 4S p. P190-P191
artikel
508 Dementia in Malta: Experiences of dementia patients and their caregivers Scerri, Charles
2009
5 4S p. P234
artikel
509 Dementia in multiple sclerosis: is it Alzheimer's or a new entity? Kohler, Jürgen
2009
5 4S p. P504-P505
artikel
510 Dementia knowledge and services in general practice in Australia B. Millard, Fiona
2009
5 4S p. P276
artikel
511 Dementia literacy: Public understanding of known risk factors Jackson, Colleen E.
2009
5 4S p. P410-P411
artikel
512 Demographic characteristics in Alzheimer disease patients cannot predict the response in sholinesterase inhibitors therapy Tsolaki, Magda
2009
5 4S p. P340
artikel
513 Demographic characterization and risk factors for Alzheimer's disease in patients from the UBC clinic for Alzheimer disease and related disorders Butler, Rachel
2009
5 4S p. P378
artikel
514 DemTect B: A parallel version of a cognitive screening tool to detect mild cognitive impairment and dementia Kalbe, Elke
2009
5 4S p. P454
artikel
515 DeNdritic pathology in Alzheimer's disease Baloyannis, Stavros I.
2009
5 4S p. P299
artikel
516 Dendritic pathology in Alzheimer's disease Baloyannis, Stavros I.
2009
5 4S p. P40
artikel
517 Depression and progression of cognitive function in Chinese older persons with mild cognitive impairment: A 2-year follow up Tam, Cindy W.C.
2009
5 4S p. P365
artikel
518 Depression score as an independent predictor of memory and global cognitive decline in older women: The cognitive change in women ancillary study to the women's health initiative Dunn, Julie E.
2009
5 4S p. P379-P380
artikel
519 Depressive disorder and brain atrophy in a population-based cohort of elderly people without dementia Geerlings, Mirjam I.
2009
5 4S p. P104
artikel
520 Depressive symptoms in midlife and risk of dementia four decades later in female members of an integrated health care delivery system Barnes, Deborah E.
2009
5 4S p. P386
artikel
521 Depressive symptoms predict cognitive impairment in nondisabled elderly with white matter changes: The LADIS study Verdelho, Ana
2009
5 4S p. P105-P106
artikel
522 Descriptive analysis of elderly from different institutions of the Brazilian Middle-West: Evaluation of cognitive decrease and functional capacity Souza, Fernando José
2009
5 4S p. P294
artikel
523 Design And Pharmacological Evaluation Of Caged Dimebon Analogues: Novel Neuroprotectors And Cognition Enhancers For Treating Alzheimer'S Disease Nenajdenko, Valentine
2009
5 4S p. e31-e32
artikel
524 Design and quality of life in patients who are victims of cerebral vascular accident Marques, Rita de Cássia G.
2009
5 4S p. P329
artikel
525 Designing Early (pre-dementia) Alzheimer's Disease Trials: Linear Mixed Models Versus Time To Conversion Donohue, Michael
2009
5 4S p. e19-e20
artikel
526 Design of care facilities for people with Alzheimer's disease van der Eerden, William J.
2009
5 4S p. P238
artikel
527 Detecting preclinical neurodegeneration: An example from Huntington's disease Kloppel, Stefan
2009
5 4S p. P53
artikel
528 Detection of β-amyloid plaques in human AD brain tissue specimen using MR imaging H. Kitzler, Hagen
2009
5 4S p. P267
artikel
529 Detection of β-amyloid plaques in human Alzheimer brain tissue specimen using MR imaging Kitzler, Hagen H.
2009
5 4S p. P56
artikel
530 Detection of changes in cerebral blood flow perfusion following Aricept® treatment in mild Alzheimer's disease subjects Antuono, Piero
2009
5 4S p. P327
artikel
531 Detection of changes in cerebral blood flow perfusion following aricept® treatment in mild Alzheimer subjects Antuono, Piero
2009
5 4S p. P66
artikel
532 Detection of changes in functional connectivity following aricept® treatment in mild Alzheimer disease subjects Li, Shi-Jiang
2009
5 4S p. P66
artikel
533 Detection of changes in functional connectivity following Aricept® treatment in Mild Alzheimer's disease subjects Li, Shi-Jiang
2009
5 4S p. P327
artikel
534 Detection of cognitive impairment in the elderly by general practitioners in Brazil Jacinto, Alessandro F.
2009
5 4S p. P189-P190
artikel
535 Detection of gender specific differences in the diagnosis of Alzheimer's disease via high-resolution blood-gene expression Einstein, Richard
2009
5 4S p. P350
artikel
536 Detection of hippocampal volume changes on elderly control, MCI and AD patients from the ADNI database: a one-year follow-up Belaroussi, Boubakeur
2009
5 4S p. P202-P203
artikel
537 Detection of hippocampal volume changes on elderly control, MCI and Alzheimer patients from the ADNI database: A one-year follow up Belaroussi, Boubakeur
2009
5 4S p. P31
artikel
538 Detection of memory decline in “healthy” community volunteers within 6 months Darby, David
2009
5 4S p. P354
artikel
539 Detection validity of the digit span and the word span for dementia Kochhann, Renata
2009
5 4S p. P447-P448
artikel
540 Determinants of course patterns of Mild Cognitive Impairment (MCI) Kaduszkiewicz, Hanna
2009
5 4S p. P381
artikel
541 Determination of beta-amyloid peptide signatures in cerebrospinal fluid of familial Alzheimer's disease mutated patients Ghidoni, Roberta
2009
5 4S p. P301
artikel
542 Developing a culturally competent internet-based intervention for caregivers of older patients with dementia Chen, Hongtu
2009
5 4S p. P90-P91
artikel
543 Development of abeta vaccine for the treatment of dog cognitive dysfunction syndrome Bosch, Neus
2009
5 4S p. P431
artikel
544 Development of Alzheimer AFFITOPE vaccines - from concept to clinical testing Schneeberger, Achim
2009
5 4S p. P257
artikel
545 Development of an algorithm for identifying Alzheimer's disease severity in administrative claims data Mucha, Lisa
2009
5 4S p. P97
artikel
546 Development of aptamers that bind to BACE1 Arnold, Stephen J.
2009
5 4S p. P416
artikel
547 Development of conformational FRET- based detection of amyloid beta oligomers in clinical samples Soukharev, Serguei
2009
5 4S p. P351
artikel
548 Development of early diagnostics and therapies for Alzheimer's disease Fedoriv, Ivan V.
2009
5 4S p. P65
artikel
549 Development of early diagnostics and therapies for Alzheimer's disease Fedoriv, Ivan V.
2009
5 4S p. P323
artikel
550 Development of neuropeptides that promote neurogenesis in models of Alzheimer's and Parkinson's disease Rockenstein, Edward
2009
5 4S p. P440
artikel
551 Development of neurotrophic peptides for enhancement of neurogenesis and associated behavioral improvement Grundke-Iqbal, Inge
2009
5 4S p. P139
artikel
552 Development Of Tau Stable-expressed Hek293 Cell For Drug Screening Of Gsk-3b Inhibitor Cho, Goang-Won
2009
5 4S p. e9
artikel
553 Diabetes and cognitive impairment in the accord mind trial and in chronic kidney disease Murray, Ann
2009
5 4S p. P123
artikel
554 Diabetes as a risk factor for mild cognitive impairment in a population-based sample in Germany Schröder, Johannes
2009
5 4S p. P385
artikel
555 Diagnosing Ad by Detecting Oligomeric Forms of Beta-amyloid In Bodily Fluids An, Seong
2009
5 4S p. e2
artikel
556 Diagnosis and prevalence of dementia in Indigenous Australians Logiudice, Dina
2009
5 4S p. P121
artikel
557 Diagnosis of dementia and Alzheimer's disease in Indianapolis and Ibadan: challenges in cross-cultural studies of aging and dementia Hendrie, Hugh
2009
5 4S p. P122
artikel
558 Diagnostic correlates of Alzheimer's dementia Preuss, Ulrich W.
2009
5 4S p. P377
artikel
559 Diagnostic efficacy of manual tracing versus voxel based morphometry of the hippocampus in MCI D. Agonafer, Senayet
2009
5 4S p. P264
artikel
560 Diagnostic Test Accuracy in dementia: A programme of systematic Cochrane Reviews McShane, R.
2009
5 4S p. P277-P278
artikel
561 Diagnostic usefulness of verbal fluency test in dementia patients with a one-year follow up Lee, Ho-Won
2009
5 4S p. P14
artikel
562 Diagnostic usefulness of verbal fluency test in dementia patients with a one-year follow up Lee, Ho-Won
2009
5 4S p. P458
artikel
563 Diagnostic Utility of Diffusion Tensor Imaging and Deformation-Based Morphometry for the Assessment of Alzheimer's Disease Teipel, Stefan J.
2009
5 4S p. P56
artikel
564 Diagnostic utility of platelet amyloid precursor protein ratio, red blood cells and plasma beta amyloid (Aβ 1-42) levels in late-onset Alzheimer's disease Ashok, Ben
2009
5 4S p. P347
artikel
565 Diagnostic utility of platelet amyloid precursor protein ratio, red blood cells and plasma beta amyloid (Aβ 1-42) levels in late-onset Alzheimer's disease Ashok, Ben
2009
5 4S p. P9-P10
artikel
566 Diagnostic utility of the AD8 informant interview in mild cognitive impairment (MCI) and dementia in an Asian population Chong, Mei Sian
2009
5 4S p. P359
artikel
567 Dietary DHA supplementation leads to synaptic protection and cognitive preservation in an Alzheimer's disease mouse model Oster, Thierry
2009
5 4S p. P181-P182
artikel
568 Dietary induction of type 2 diabetes increases AD-like pathology in male 3xTg-AD mice Rosario, Emily R.
2009
5 4S p. e28-e29
artikel
569 Dietary induction of type 2 diabetes increases Alzheimer-like pathology in male 3xTg-AD mice Rosario, Emily R.
2009
5 4S p. P441
artikel
570 Dietary patterns associated with Alzheimer's disease - A population based study (BERCAL) Gustaw, Katarzyna A.
2009
5 4S p. P296-P297
artikel
571 Differences in MRI measures of brain volume, white matter hyperintensities and infarcts in Chinese: The Shanghai Community Brain Health Initiative (SCOBHI) DeCarli, Charles
2009
5 4S p. P37-P38
artikel
572 Differences in MRI measures of brain volume, white matter hyperintensities and infarcts in Chinese: The Shanghai Community Brain Health Initiative (SCOBHI) DeCarli, Charles
2009
5 4S p. P382
artikel
573 Differences of cognitive functions and activity of daily living according to presence of depressive symptoms among dementia patients Kim, Moon-Doo
2009
5 4S p. P187
artikel
574 Differences of neuropsychological function and behavioral symptoms between depressive elderly patients with or without subjective memory complaint Kim, Moon-Doo
2009
5 4S p. P451
artikel
575 Different anatomical subtypes of behavioral variant frontotemporal dementia identified using cluster analysis Whitwell, Jennifer L.
2009
5 4S p. P506
artikel
576 Different characteristics of cognitive impairment in Alzheimer's disease in the mild cognitive impairment stage and elderly schizophrenia Kazui, Hiroaki
2009
5 4S p. e27
artikel
577 Different effect of ApoE4 and E3 on gray matter loss in Alzheimer's disease Yang, Dong Won
2009
5 4S p. P41
artikel
578 Different effect of APOE4 and E3 on gray matter loss in Alzheimer's disease Yang, Dong Won
2009
5 4S p. P211
artikel
579 Differential diagnosis of neurodegenerative dementias using structural MRI Vemuri, Prashanthi
2009
5 4S p. P16
artikel
580 Differential diagnosis of neurodegenerative diseases using serum: A new paradigm Goldknopf, Ira L.
2009
5 4S p. P346
artikel
581 Differential DNA methylation in neurons of identical twins discordant for Alzheimer's disease Mastroeni, Diego
2009
5 4S p. P145-P146
artikel
582 Differential effect of APOE 4 allele on Amyloid beta accumulation in AD and non-AD Ishii, Kenji
2009
5 4S p. P369
artikel
583 Differential effect of APOE 4 allele on Amyloid beta accumulation in Alzheimer's disease and non-Alzheimer's disease Ishii, Kenji
2009
5 4S p. P27
artikel
584 Differential effects of age on tau protein expression in the rat brain following chronic nicotine administration in vivo Scerri, Charles
2009
5 4S p. P431
artikel
585 Differential Expression Of Cell Surface Proteins In Human Bone Marrow Mesenchymal Stem Cells Cultured With Or Without Basic Fibroblast Growth Factor Containing Medium Lee, Sang Kwang
2009
5 4S p. e11
artikel
586 Differential expression of ChAT mRNA splice variants in the mouse basal forebrain cholinergic neurons Trifonov, Stefan
2009
5 4S p. P498
artikel
587 Differential patterns of atrophy in behavioral versus language subtypes of frontotemporal lobar degeneration: A tensor-based morphometry study Lu, Po-Haong
2009
5 4S p. P204
artikel
588 Differential patterns of atrophy in behavioral versus language subtypes of frontotemporal lobar degeneration: A tensor-based morphometry study Lu, Po-Haong
2009
5 4S p. P34
artikel
589 Differential patterns of grey matter alterations in Alzheimer's disease and in frontotemporal dementia: evidence from a voxel-based study on DTI Allard, Michèle
2009
5 4S p. P217-P218
artikel
590 Differentiating Alzheimer's Disease From Vascular Dementia With EEG Functional Neuroimaging Kilborn, Kerry W.
2009
5 4S p. e24
artikel
591 Differentiating the frontal variant of Alzheimer's disease Woodward, Michael
2009
5 4S p. P187
artikel
592 Diffusion tensor imaging characteristics of amnestic and non-amnestic mild cognitive impairment Kantarci, Kejal
2009
5 4S p. P12
artikel
593 Diffusion tensor imaging characteristics of dementia with Lewy bodies and Alzheimer's disease Kantarci, Kejal
2009
5 4S p. P163
artikel
594 Diffusion tensor MRI assessment of white matter fibers changes in Alzheimer's disease and mild cognitive impairment Pievani, Michela
2009
5 4S p. P100-P101
artikel
595 Diffusion tensor tractography of white matter tracts within the temporal stem in Alzhiemer disease on 3 tesla MRI Kumari, Rima
2009
5 4S p. P367
artikel
596 Dimebon®: A Clinically Promising Drug for Alzheimer's Disease, Regulates Amyloid-Beta Metabolism in Cultured Cells, In Isolated Nerve Terminals, and In the Interstitial Fluid of the Living Rodent Brain Gandy, Sam
2009
5 4S p. e5
artikel
597 Direct evidences that macroautophagy basal activity is low in cultured neurons Magnaudeix, Amandine
2009
5 4S p. P487
artikel
598 Disaggregation of β-amyloid plaques by KMSB600 Kim, HyeYun
2009
5 4S p. P421
artikel
599 Discovery of a highly M5-preferring muscarinic acetylcholine receptor allosteric potentiator Bridges, Thomas M.
2009
5 4S p. P321
artikel
600 Discriminant validity for the proposed NINDS-CSN harmonization vascular cognitive impairment neuropsychological assessment protocols Nyenhuis, David
2009
5 4S p. P505
artikel
601 Discriminating healthy elderly, MCI, mild and moderate Alzheimer's disease: The Computerized Neuropsychological Test Battery (CNTB) Veroff, Amy E.
2009
5 4S p. P455
artikel
602 Disease modification: Relationship with cognitive decline rates and slope analysis Hendrix, Suzanne
2009
5 4S p. P143
artikel
603 Disease-modifying trial in Alzheimer's Disease (AD): What should be the place of cognitive testing? Touchon, Jacques
2009
5 4S p. P143
artikel
604 Disease progression analysis of ADAS-cog from ADNI database in normal elderly, mild cognitive impairment and Alzheimer's disease patients Ito, Kaori
2009
5 4S p. P255
artikel
605 Disease progression of cognitive impairment in Alzheimer's disease: A model-based approach Willavize, Susan
2009
5 4S p. P253
artikel
606 Dissociated Aβ antibody level in newly diagnosed Alzheimer's disease: A population-based study Gustaw-Rothenberg, Katarzyna
2009
5 4S p. P363
artikel
607 Dissociation of synaptic dysfunction and behavior in a tauopathy mouse model (PrP-MAPT) of Alzheimer's disease Zaleska, Margaret
2009
5 4S p. P446-P447
artikel
608 Distinct activation patterns for associative encoding in presymptomatic individuals with familial Alzheimer's disease due to E280A presenilin-1 mutation Quiroz, Yakeel T.
2009
5 4S p. P23
artikel
609 Distinct activation patterns for associative encoding in pre-symptomatic individuals with familial Alzheimer's disease due to E280A presenilin-1 mutation Quiroz, Yakeel T.
2009
5 4S p. P199
artikel
610 Distinction between episodic and autobiographical memory in aMCI patients Matura, Silke
2009
5 4S p. P355
artikel
611 Distinct tau aggregation form involved in synapse loss and neuron loss Takashima, Akihiko
2009
5 4S p. P399
artikel
612 Divergent effects of HIF-1α in rat model of transient focal cerebral ischemia Yeh, Shiu-Hwa
2009
5 4S p. P495
artikel
613 3D mapping of associations amongst amyloid-PET and CSF biomarkers and hippocampal morphology Andrawis, John P.
2009
5 4S p. P197-P198
artikel
614 3-D mapping of associations amongst amyloid-PET and CSF biomarkers and hippocampal morphology Andrawis, John P.
2009
5 4S p. P21
artikel
615 3-D mapping of episodic memory and executive function in late-onset depression Wang, Huali
2009
5 4S p. P13
artikel
616 3-D mapping of episodic memory and executive function in late-onset depression Wang, Huali
2009
5 4S p. P373
artikel
617 3-D mapping of verbal fluency performance in amnestic mild cognitive impairment and Alzheimer's disease Li, Tao
2009
5 4S p. P62-P63
artikel
618 3-D mapping of verbal fluency performance in amnestic mild cognitive impairment and Alzheimer's disease Li, Tao
2009
5 4S p. P270
artikel
619 Docosahexaenoic asid and cognition in elderly people living in community - A 4-year follow-up study Matsumoto, Ichie
2009
5 4S p. P282
artikel
620 Does Apolipoprotein E genotype interact with the effects of potentially modifiable mid- and late-life risk factors for dementia? A systematic review Low, Lee-Fay
2009
5 4S p. P384
artikel
621 Does mild cognitive impairment increase the risk for developing postoperative cognitive impairment? De Santi, Susan
2009
5 4S p. P364
artikel
622 Does Mmse Exactly Work For Diagnosing Alzheimer's Disease Huang, Yao Ting
2009
5 4S p. e10
artikel
623 Does the management of people with dementia differ in rural general practice compared to urban general practice? Greenway-Crombie, Angela M.
2009
5 4S p. P235
artikel
624 Domain-specific rates of cognitive change in MCI Reed, Bruce
2009
5 4S p. P353-P354
artikel
625 Do the biomarker findings fit the hypotheses? Nitsch, Roger
2009
5 4S p. P1
artikel
626 Drastic impact on Abeta accumulation in APP Tg mice by genetic background Yokokoji, Mikiko
2009
5 4S p. P300
artikel
627 D-ribosylated Tau forms globular aggregates with high cytotoxicity Wei, Yan
2009
5 4S p. P45
artikel
628 D-ribosylated tau forms globular aggregates with high cytotoxicity Wei, Yan
2009
5 4S p. P395
artikel
629 Driving ability in people with dementia Lincoln, Nadina B.
2009
5 4S p. P159
artikel
630 Drug design approach for the development of novel nonpeptide caspase-3 inhibitors for the treatment of Alzheimer's disease Sharma, Simant
2009
5 4S p. P426-P427
artikel
631 Duplications of APP—but not PRNP—are a significant cause of early-onset dementia in a large UK referral series Ryan, Natalie
2009
5 4S p. P460
artikel
632 Dysfunctional thoughts in Alzheimer's disease family caregivers: Does age matter? Negovanska, Velina
2009
5 4S p. P412
artikel
633 Dysregulated Endoplasmic Reticulum calcium release in Alzheimer's disease: A paradigm for high throughput drug/siRNA screens Honarnejad, Kamran
2009
5 4S p. P316
artikel
634 Dysregulation of brain ApoE and cholesterol metabolism in APP transgenic mice Warwick, Helen K.
2009
5 4S p. P446
artikel
635 Early detection and differentiation of amnestic and nonamnestic mild cognitive impairment (MCI) Zola, Stuart
2009
5 4S p. P362
artikel
636 Early diagnosis of dementia in primary care in Australia: a qualitative study into the barriers and enablers Paterson, Nerida E.
2009
5 4S p. P185
artikel
637 Early-life linguistic ability, late-life pathology and asymptomatic Alzheimer's disease: Findings from the Nun Study Tyas, Suzanne L.
2009
5 4S p. P103-P104
artikel
638 Early pathologic changes of axonal transport and neurochemical levels in 3xTg-AD mice Lee, Sang-Pil
2009
5 4S p. P210
artikel
639 Early synaptic degenerative changes in the hippocampus of PS1(M146L)xAPP(751SL) mouse model of Alzheimer's disease Sanchez-Varo, Raquel
2009
5 4S p. P439
artikel
640 Early- versus late-onset depression: Lifetime prevalence and association to mild cognitive impairment in a representative community sample Schröder, Johannes
2009
5 4S p. P385-P386
artikel
641 Early window of mortality risk on 3xTgAD mice treated with an antipsychotic drug at advanced stages of the disease Gimenez Llort, Lydia
2009
5 4S p. P291
artikel
642 Echocardiography vortex formation time reveal cardiac diastolic transmitral flow dysfunction in Alzheimer's disease patients Roher, Alex E.
2009
5 4S p. P293
artikel
643 Editorial Board 2009
5 4S p. A6
artikel
644 EEG, activity and sleep architecture in a transgenic APP/PSEN mouse Jyoti, Amar
2009
5 4S p. P437
artikel
645 EEG and cognitive effects of transcranial direct current stimulation (tDCS) in patients with Alzheimer's disease Ferrucci, Roberta
2009
5 4S p. P257-P258
artikel
646 Effectiveness and cost-effectiveness of the tailored activity program: a nonpharmacologic intervention that reduces behavioral symptoms and caregiver time Jutkowitz, Eric
2009
5 4S p. P229
artikel
647 Effectiveness of pharmacological and non pharmacological therapy in patients with MCI and Mild Alzheimer's disease Tsolaki, Magdalini
2009
5 4S p. P98
artikel
648 Effect of age on ventricular enlargement when comparing cognitively normal elderly, mild cognitive impairment and Alzheimer's disease subjects Apostolova, Liana G.
2009
5 4S p. P219-P220
artikel
649 Effect of age on ventricular enlargement when comparing cognitively normal elderly, mild cognitive impairment and Alzheimer's disease subjects Apostolova, Liana G.
2009
5 4S p. P58-P59
artikel
650 Effect of amygdale-dependent learning on tau phosphorylation in hippocampus of adult rats Yang, Ying
2009
5 4S p. P396
artikel
651 Effect of APP 5-mer peptide on production and differentiation of cultured embryo hippocampal neural stem cells originated from SD rats Meng, Yan
2009
5 4S p. P338
artikel
652 Effect of asiatic acid on hippocampal cell line: A novel inhibitor of acetylcholinesterase from Centella asiatica Boopathy, Rathanam
2009
5 4S p. P328-P329
artikel
653 Effect of coffee roasting on anti-oxidant level and neuroprotective ability against reactive oxygen species Lin, Yi-Ching
2009
5 4S p. P325
artikel
654 Effect of cognitive treatment for the elderly with mild-to-moderate Alzheimer's disease in the cognitive function and the psychological well being Wu, Wei-Ren
2009
5 4S p. P413
artikel
655 Effect of cold water stress on Tau phosphorylation and memory in rat Zhou, Xin-Wen
2009
5 4S p. P45
artikel
656 Effect of cold water stress on tau phosphorylation and memory in rat Zhou, Xin-Wen
2009
5 4S p. P397
artikel
657 Effect of cortical placement of luteinizing hormone on Aβ metabolism in guinea pigs Wijaya, Linda Kurnia
2009
5 4S p. P180
artikel
658 Effect of different concentrations of forskolin on tau phosphorylation and spatial memory in rats and the underlying mechanism Tian, Qing
2009
5 4S p. P398
artikel
659 Effect of haplotype-sequence variation on the expression of the disease-associated MAPT exon 10 Caffrey, Tara M.
2009
5 4S p. P136
artikel
660 Effect of lactoferrin on Aß neurotoxicity and its clearance Sato, Haruhisa
2009
5 4S p. P478-P479
artikel
661 Effect of L-carnitine on tau hyperphosphorylation and spatial memory deficit induced by okadaic acid in rats Zhu, Ling-Qiang
2009
5 4S p. P395-P396
artikel
662 Effect of memantine on the activity of the default mode network: A resting fMRI study Lorenzi, Marco
2009
5 4S p. P38-P39
artikel
663 Effect of memantine on the activity of the default mode network. A resting fMRI study Lorenzi, Marco
2009
5 4S p. P206
artikel
664 Effect of Pin1 and microtubule binding on dephosphorylation of FTDP-17 mutant tau Hisanaga, Shin-Ichi
2009
5 4S p. P399-P400
artikel
665 Effect of puromycin sensitive aminopeptidase overexpression on TAU protein metabolism in vivo Kudo, Lili C.
2009
5 4S p. P403
artikel
666 Effect of targeting i2 pp-2a with sirnas on alzheimer-like pathology in tg2576 mice Wei, Wei
2009
5 4S p. P222
artikel
667 Effect of targeting i2 pp-2a with sirnas on alzheimer-like pathology in tg2576 mice Wei, Wei
2009
5 4S p. P43
artikel
668 Effect of temporal lobe structure volume on memory in elderly depressed patients: A voxel-based morphometry study Avila, Renata
2009
5 4S p. P503
artikel
669 Effects and safety of nonviral abeta dna vaccine therapy in aged rhesus monkeys Matsumoto, Yoh
2009
5 4S p. P114
artikel
670 Effects of antihypertensive therapy on cognitive stability in Alzheimer's disease Duron, Emmanuelle
2009
5 4S p. P67
artikel
671 Effects of antihypertensive therapy on cognitive stability in Alzheimer's disease Duron, Emmanuelle
2009
5 4S p. P247
artikel
672 Effects of ApoE genotype but not of FAD mutation status in BOLD activation during a novelty encoding task Ringman, John M.
2009
5 4S p. P103
artikel
673 Effects of a stage-specific cognitive intervention program in patients with mild cognitive impairment (MCI) and mild Alzheimer's disease (AD) Buschert, Verena C.
2009
5 4S p. P98
artikel
674 Effects of beta-amyloid oligomers on neuronal viability and microglial activation Ferrera, Denise
2009
5 4S p. P226
artikel
675 Effects of cholinesterase inhibition on brain white matter volume in mild Alzheimer's disease Venneri, Annalena
2009
5 4S p. P332-P333
artikel
676 Effects of cornel iridoid glycoside on CNS microenvironment related to neurogenesis in AD-like rat model induced by fimbria-fornix transaction Li, Lin
2009
5 4S p. P328
artikel
677 Effects of cornel iridoid glycoside on CNS microenvironment related to neurogenesis in Alzheimer-like rat model induced by fimbria-fornix transaction Li, Lin
2009
5 4S p. P66
artikel
678 Effects of donepezil on structural MRI and clinical markers in patients with amnestic mild cognitive impairment: A randomized, placebo-controlled trial Dubois, Bruno
2009
5 4S p. P269
artikel
679 Effects of extracts from traditional chinese medical plants on glycogen synthase kinase 3β activity and COS7 cells Kaufmann, Dorothea
2009
5 4S p. P322
artikel
680 Effects of head circumference and metabolic syndrome on cognitive decline Lee, Kang Soo
2009
5 4S p. P287
artikel
681 Effects of memantine and donepezil on object recognition memory in rats with cholinergic lesions Ihalainen, Jouni
2009
5 4S p. P181
artikel
682 Effects of memantine on functional communication in patients with moderate AD: Results of a 12-week placebo-controlled trial Hofbauer, Robert K.
2009
5 4S p. P256-P257
artikel
683 Effects of 12 months of treatment with the PPARγ agonist rosiglitazone on brain glucose metabolism in Alzheimer's disease: A 18F-FDG PET study Rabiner, Eugenii A.
2009
5 4S p. P39-P40
artikel
684 Effects of 12 months of treatment with the PPARγ agonist rosiglitazone on brain glucose metabolism in Alzheimer's Disease: A 18F-FDG PET study Rabiner, Eugenii A.
2009
5 4S p. P207
artikel
685 Effects of physical activity and high density lipoprotein cholesterol (HDL) on cognitive performance: The Third National Health and Nutrition Examination Survey (NHANES III) Hamilton, Jamie L.
2009
5 4S p. P294
artikel
686 Effects of repeated screening and potential impact on AD prevention trial design: The antioxidant AD prevention (PREADVISE) trial Schmitt, Frederick A.
2009
5 4S p. P258
artikel
687 Effects of rivastigmine on brain white matter volume in Mild Cognitive Impairment (MCI) Ferris, Steven
2009
5 4S p. P332
artikel
688 Effects of rosiglitazone as monotherapy in APOE4-stratified subjects with mild-to-moderate Alzheimer's disease Gold, Michael
2009
5 4S p. P86
artikel
689 Effects Of Rosiglitazone-extended Release As Adjunctive Therapy To Acetylcholinesterase Inhibitors Over 48 Weeks On Cognition In Apoe4-stratified Subjects With Mild-to-moderate Alzheimer'S Disease Harrington, Conn
2009
5 4S p. e17-e18
artikel
690 Effects of secretase inhibitors on APP processing in primary cultures of embryonic chicken cortical neurons Czvitkovich, Stefan
2009
5 4S p. P303
artikel
691 Effects of the novel histamine H3 receptor antagonist S 38093 in a non-human primate model of cognitive dysfunction Schneider, Jay S.
2009
5 4S p. e31
artikel
692 Effects of the novel histamine H3 receptor antagonist S 38093 in a non-human primate model of cognitive dysfunction Schneider, Jay S.
2009
5 4S p. P245
artikel
693 Effects of walking on the rest-activity rhythm in older adults with dementia: A randomized controlled trial Eggermont, Laura H.P.
2009
5 4S p. P244
artikel
694 Effects of white matter changes on cognitions and activities of daily living in mild to moderate dementia: Korean multicenter MR 500 in CREDOS (Clinical research center for dementia of South Korea) Study Hyung Park, Kee
2009
5 4S p. P271
artikel
695 Effects of zinc plus cyclo(his-pro) on pathology, learning and memory in a transgenic mouse model of Alzheimer's disease O'Barr, Stephen A.
2009
5 4S p. P243
artikel
696 Efficacy and tolerability of Memantine in Alzheimer's disease - results of an observational study Frölich, Lutz
2009
5 4S p. P249
artikel
697 Efficacy of [18F]BAY94-9172 Positron Emission Tomography in the Detection/Exclusion of Cerebral Amyloid Beta in Patients with Probable Alzheimer's Disease Compared with Healthy Volunteers: An Open-label, Global, Multicentre Study Barthel, Henryk
2009
5 4S p. e33
artikel
698 Efficacy Of Neurofeedback For Executive And Memory Function In Dementia Berman, Marvin H.
2009
5 4S p. e8
artikel
699 E-Health and Assistive Technology (AT) as suitable answers to global aging Spiru, Luiza
2009
5 4S p. P241
artikel
700 ELAVL4 locus confirmed in depression of Alzheimer's disease Slifer, Michael A.
2009
5 4S p. P468
artikel
701 Electroencephalographic Evidence for Retrogenesis Borza, Liana R.
2009
5 4S p. e8
artikel
702 Elevated CSF levels of neurofilament proteins in sporadic Creutzfeldt-Jakob disease Verbeek, Marcel M.
2009
5 4S p. P343
artikel
703 Elevated 3-Hydroxykynurenine serum levels in Alzheimer's disease Schwarz, Markus J.
2009
5 4S p. P349
artikel
704 ELISA-based measurement of plasma total Aβ1-40 and Aβ1-42, and CSF total and free Aβ1-40 and Aβ1-42 in the presence of solanezumab, a mid-domain anti-A beta antibody Dean, Robert A.
2009
5 4S p. P133
artikel
705 ELND005 (scyllo-inositol), the β-amyloid anti-aggregation therapeutic, demonstrates robust brain uptake in rats following oral administration Quinn, Kevin
2009
5 4S p. e26
artikel
706 Emerging Computational Strategies Identify MyD88 As Downstream Target In Interleukin-1α Induced Signal Transduction In Alzheimer's Disease Mitrasinovic, Olivera M.
2009
5 4S p. e21-e22
artikel
707 Endoplasmic reticulum stress in aged P301L tau transgenic mice Yang, Xifei
2009
5 4S p. P397-P398
artikel
708 Endoplasmic reticulum stress-induced hyperphosphorylation of tau by activating GSK-3β Fu, Zhengqi
2009
5 4S p. P43-P44
artikel
709 Endoplasmic reticulum stress-induced hyperphosphorylation of tau by activating GSK-3β Fu, Zhengqi
2009
5 4S p. P473
artikel
710 Enhanced amyloid plaque detection by magnetic resonance balanced steady state free precession imaging combined with susceptibility weighted imaging post-processing Penner, Jacob
2009
5 4S p. P217
artikel
711 Enhanced amyloid plaque detection by magnetic resonance balanced steady state free precession imaging combined with susceptibility weighted imaging post-processing Penner, Jacob
2009
5 4S p. P54
artikel
712 Enhanced apoptosis and mitochondria dysfunction in lymphocytes from FAD and SAD patients Bialopiotrowicz, Emilia J.
2009
5 4S p. P313
artikel
713 Enhanced conversion of cholesterol to 24s-hydroxycholesterol decreases amyloid-ß and prevents alzheimer phenotype of app23 mouse model Cartier, Nathalie
2009
5 4S p. P138
artikel
714 Enoxaparin improves cognition of APPswe/PS1dE9 and TgSwDI mice with minor effect on amyloid β levels Timmer, Nienke M.
2009
5 4S p. P416-P417
artikel
715 Epidemiologic analyses using neuropathologic endophenotypes -- the Honolulu-Asia aging study White, Lon
2009
5 4S p. P96
artikel
716 Epidemiology of Amnestic Mild Cognitive Impairment, Nonamnestic Mild Cognitive Impairment and Dementia in a Community Based Population: Results from the Einstein Aging Study Katz, Mindy J.
2009
5 4S p. P285-P286
artikel
717 Epidemiology of Frontotemporal dementia in southern Italy Bruni, Amalia C.
2009
5 4S p. P392-P393
artikel
718 Epigenetic changes related to beta-amyloid-implications for Alzheimer's disease Lithner, Christina Unger
2009
5 4S p. P304
artikel
719 Epigenetic control of Aquaporin 1 expression by the amyloid precursor protein Huysseune, Sandra
2009
5 4S p. P496
artikel
720 Epigenetic factors in aging and their implications in geroprotectors' design Natalia, Cucu
2009
5 4S p. P489
artikel
721 Epigenetics Zukin, Suzann
2009
5 4S p. P146-P147
artikel
722 Episodic memory tests in the early diagnosis of Alzheimer's disease: the index study experience Jacova, Claudia
2009
5 4S p. P99
artikel
723 Establishing the degree of malnutrition and its risks in elderly patients with Alzheimer disease - the results of our multicentric study on 156 patients Navratilova, Miroslava
2009
5 4S p. P334-P335
artikel
724 Establishing the degree of malnutrition and its risks in elderly patients with Alzheimer's disease: The results of our multicentric study on 156 patients Navratilova, Miroslava
2009
5 4S p. P67
artikel
725 Estimating clinical variables from brain images using Bayesian regression Fan, Yong
2009
5 4S p. P372
artikel
726 Estimating dependence scale scores based on clinical dementia rating - sum of boxes scores in patients with mild cognitive impairment or mild to moderate Alzheimer's disease Cohen, Josh T.
2009
5 4S p. P238-P239
artikel
727 Estimating health-related quality of life for unique dependence levels in patients with Alzheimer's disease Murman, Daniel L.
2009
5 4S p. P236-P237
artikel
728 Estrogen receptor alpha (ESR1) gene variants are associated to Alzheimer's disease in Spanish population Boada, Mercè
2009
5 4S p. P461-P462
artikel
729 Ethical issues in recruitment of at risk healthy individuals to clinical trials involving greater than minimal risk Pierce, Robin
2009
5 4S p. P258
artikel
730 Evaluating results of a 6 month intervention program in a dementia day care center Efthymiou, Areti
2009
5 4S p. P97-P98
artikel
731 Evaluation of chaperone-like activity of alginate to protect NT2 neurons against H2O2-induced amyloid beta formation and cytotoxicity Khodagholi, Fariba
2009
5 4S p. P313-P314
artikel
732 Evaluation of chaperone-like activity of alginate to protect NT2 neurons against H2O2-Induced amyloid beta formation and cytotoxicity Khodagholi, Fariba
2009
5 4S p. P46
artikel
733 Evaluation of diabetic brains for Alzheimer changes Newell, Kathy L.
2009
5 4S p. P298
artikel
734 Evaluation of hippocampal structures in mild cognitive impairment and Alzheimer disease by 3 tesla MRI Takahashi, Junko
2009
5 4S p. P263
artikel
735 Evidence linking the continuum of hyperinsulinemia to Alzheimer's disease Luchsinger, Jose A.
2009
5 4S p. P122
artikel
736 Evidence Of An Interaction Between APOE And IDE In Ketone Body Therapies In Mild To Moderate Alzheimer'S Disease Henderson, Samuel T.
2009
5 4S p. e24-e25
artikel
737 Evp-6124: Safety, Tolerability And Cognitive Effects Of A Novel A7 Nicotinic Receptor Agonist In Alzheimer'S Disease Patients On Stable Donepezil Or Rivastigmine Therapy Hilt, Dana
2009
5 4S p. e32
artikel
738 Examination of default mode network activity along the cognitive continuum: Normal aging, MCI and AD M. Machulda, Mary
2009
5 4S p. P268
artikel
739 Examination of default mode network activity along the cognitive continuum: Normal aging, MCI and Alzheimer's disease Machulda, Mary M.
2009
5 4S p. P61
artikel
740 Examination of TOMM40, APOE, and PCDH11X in Caribbean Hispanics with late-onset Alzheimer's disease Lee, Joseph H.
2009
5 4S p. P472
artikel
741 Examining the link between synaptosomal accumulation of tau protein and cognitive dysfunction Sahara, Naruhiko
2009
5 4S p. P397
artikel
742 Examining the role of ApoE in LXR-Mediated Aβ clearance mechanisms: Implications for the development of Alzheimer's disease therapeutics Riddell, David
2009
5 4S p. P167-P168
artikel
743 Excitotoxic damage deregulates tau phosphorylation: Implication to Alzheimer's disease Liang, Zhihou
2009
5 4S p. P396
artikel
744 Exclusion of phosporylated APP CTFs from membrane region rich in active γ-secretase Matsushima, Takahide
2009
5 4S p. P223
artikel
745 Exebryl-1: A novel small molecule currently in human clinical trials as a disease-modifying drug for the treatment of Alzheimer's disease Snow, Alan D.
2009
5 4S p. P418
artikel
746 Executive function in progressive and nonprogressive behavioural variant frontotemporal dementia Hornberger, Michael
2009
5 4S p. P162
artikel
747 Exercise and longevity in Alzheimer's disease Scarmeas, Nikolaos
2009
5 4S p. P80
artikel
748 Exploring the association between plasma apoE levels and Alzheimer's disease: Australian Imaging, Biomarker and Lifestyle (AIBL) flagship study of ageing Martins, Ralph
2009
5 4S p. P308-P309
artikel
749 Exploring the effect of a change in plasma membrane cholesterol on the lipid rafts-partitioning of APP using fluorescence correlation spectroscopy (FCS) Marquer, Catherine
2009
5 4S p. P88
artikel
750 Exploring the effect of combined β- & γ-secretase inhibitor treatment on βAPP processing in a transfected SHSY5Y cell line Haugabook, Sharie J.
2009
5 4S p. P429
artikel
751 Extracellular amyloid-beta pathology induces entorhinal neurodegeneration in PS1(M146L)xAPP(751SL) mouse model of Alzheimer's disease Moreno-Gonzalez, Ines
2009
5 4S p. P439
artikel
752 Facilitators and barriers for implementation of an easy, care-based Dementia Training Programme for general practitioners and primary care nurses: A qualitative study Perry, Marieke
2009
5 4S p. P140-P141
artikel
753 Factorial analysis of the symptoms in the neuropsychiatric inventory Borba, Ericksen
2009
5 4S p. P184
artikel
754 Factors associated with the absence of cognitive impairment in pathologically defined Alzheimer's disease (AD) Grinberg, Lea T.
2009
5 4S p. P298-P299
artikel
755 Factors related to learning time of digital instruments by elder people with cognitive impairments André Junqueira Xavier,
2009
5 4S p. P276-P277
artikel
756 False recognition in Alzheimer's disease and mild cognitive impairment Koide, Reiko
2009
5 4S p. P452
artikel
757 Familial aggregation of dementia with lewy bodies Nervi, Angela
2009
5 4S p. P390
artikel
758 Familial and sporadic Alzheimer's disease: A clinical longitudinal study Talarico, Giuseppina
2009
5 4S p. P193
artikel
759 Familiarity-based recognition in multidomain amnestic and nonamnestic cognitive impaired patients: A follow-up retest Algarabel, Salvador
2009
5 4S p. P359-P360
artikel
760 [18F]BAY 94-9172 PET - Towards in vivo quantification of brain β-amyloid plaque load in Alzheimer disease Sabri, Osama
2009
5 4S p. P260
artikel
761 [18F]BAY 94-9172 PET: Towards in vivo quantification of brain β-amyloid plaque load in Alzheimer's disease Sabri, Osama
2009
5 4S p. P47
artikel
762 Feeling emotions without overt recognition: A case of semantic dementia Calabria, Marco
2009
5 4S p. P448-P449
artikel
763 Fine SNP mapping in and around the APOE in late-onset Alzheimer disease Kuwano, Ryozo
2009
5 4S p. P463-P464
artikel
764 Flavonoids and Alzheimer's disease prevention: An ecological analysis of potential neuroprotective dietary factors Beking, Kris J.
2009
5 4S p. P286-P287
artikel
765 fMRI encoding task correlation with voxel-based morphometry of the hippocampus in healthy controls, mild cognitive impairment, and Alzheimer's disease Petrella, Jeffrey R.
2009
5 4S p. P127
artikel
766 Focal spatial memory dysfunction in mild cognitive impairment: Amnestic variant Papp, Kathryn V.
2009
5 4S p. P357
artikel
767 Forebrain neuron-specific Atg7-deficient mice display tau pathology Inoue, Keiichi
2009
5 4S p. P399
artikel
768 Formation and maintenance of β-amyloid plaques in the absence of microglia Grathwohl, Stefan
2009
5 4S p. P439-P440
artikel
769 Foundation for the National Institutes of Health: Facilitating the Development and Qualification of Alzheimer's Disease Biomarkers Through Novel Public-Private Partnerships Lee, David B.
2009
5 4S p. e26-e27
artikel
770 Four years study to delay Alzheimer's progress using cognitive stimulation multimedia systems in Mexico Villa Esteves, Victor Fdo
2009
5 4S p. P242
artikel
771 Fractal analysis of amyloid plaques in Alzheimer's disease patients and mouse models Kumar-Singh, Samir
2009
5 4S p. P107
artikel
772 Frailty and Alzheimer's disease in older men and women: Results from a population-based study Song, Xiaowei
2009
5 4S p. P129
artikel
773 From mild cognitive impairment to Alzheimer's disease: comparisons of metabolic and structural brain alteration evolutions Villain, Nicolas
2009
5 4S p. P3-P4
artikel
774 Frontotemporal Dementia With FUS Pathology Mackenzie, Ian R.
2009
5 4S p. e4
artikel
775 Frontotemporal Lobe Involvement In Advanced Amyotrophic Lateral Sclerosis Watanabe, Chigusa
2009
5 4S p. e15
artikel
776 Functional capacity, cognitive deficit and falls in Alzheimer's disease: A pilot study Fonsêca, Cristiane M.
2009
5 4S p. P289
artikel
777 Functional connectivity alterations of visual processing in Alzheimer's disease Bokde, Arun
2009
5 4S p. P198-P199
artikel
778 Functional decline concomitant to mental status stability in a 12-Year follow-up of Brazilian healthy elderly Chaves, Marcia Lorena
2009
5 4S p. P285
artikel
779 Functional mechanisms of nuclear translocated alpha-synuclein Suh, Yoo-Hun
2009
5 4S p. P124
artikel
780 Fyn kinase regulates phosphorylation and localization of APP and Dab1 to lipid rafts Minami, S. Sakura
2009
5 4S p. P494
artikel
781 Galantamine has no effect on platelet function in the elderly Turan Isik, Ahmet
2009
5 4S p. P338-P339
artikel
782 Galantamine improves behavioural disturbances in outpatients with mild to moderate Alzheimer's disease Ibach, Bernd
2009
5 4S p. P244
artikel
783 Galantamine is safe as well as metoprolol on cardiac electrophysiology of patients with Alzheimer's disease Bozoglu, Ergun
2009
5 4S p. P339
artikel
784 Gamma-secretase promotes the ephrinB-mediated angiogenesis Georgakopoulos, Anastasios
2009
5 4S p. P317
artikel
785 Genetic analysis of expression and association in Alzheimer's disease Morgan, Kevin
2009
5 4S p. P169-P170
artikel
786 Genetic Analysis Of The Polymorphisms In The Beta And Gamma Secretase Complex And Its Association With Alzheimer's Disease In Mexican Patients Campos-Peña, Victoria
2009
5 4S p. e32
artikel
787 Genetic counseling for early onset familial Alzheimer's disease in a large aboriginal kindred from a remote community in northern British Columbia: Unique challenges and possible solutions Butler, Rachel
2009
5 4S p. P90
artikel
788 Genetic predictors of 12-month change in MRI hippocampal volume in the Alzheimer's Disease Neuroimaging Initiative cohort: Analysis of leading candidates from the AlzGene database Saykin, Andrew J.
2009
5 4S p. P3
artikel
789 Genetic screening for components mediating α-synuclein toxicity in a humanized yeast model system Franssens, Vanessa D.L.
2009
5 4S p. P440
artikel
790 Genetic screens in yeast to identify modifiers of beta-amyloid-induced toxicity Sia, Angela M.
2009
5 4S p. P177
artikel
791 Genetic studies of dementia and related traits Van Duijn, Cornelia M.
2009
5 4S p. P96
artikel
792 Genetic variants in presenilins and correlation to amyloid-beta 42 levels in cerebrospinal fluid and diagnosis of Alzheimer's disease von Arnim, Christine A.F.
2009
5 4S p. P465
artikel
793 Genetic variants in 14q chromosomal region are associated with memory in late-onset Alzheimer's disease Barral, Sandra
2009
5 4S p. P150
artikel
794 Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease Carrasquillo, Minerva M.
2009
5 4S p. P150
artikel
795 Genome-wide association analysis of Alzheimer's disease Amouyel, Philippe
2009
5 4S p. P170
artikel
796 Genome-wide association study for dementia in the midwestern US Amish Haines, Jonathan L.
2009
5 4S p. P464-P465
artikel
797 Genome-Wide Association Study (GWAS) of plasma Aß levels in the dalmatian islands of Vis and korcula Allen, Mariet
2009
5 4S p. P149
artikel
798 Genome-wide association study of age at onset of Alzheimer's disease Harold, Denise
2009
5 4S p. P471
artikel
799 Genome-wide association study of Alzheimer's with psychotic symptoms Hollingworth, Paul
2009
5 4S p. P467
artikel
800 Genome-wide association study validates associations in APOE, VDR, SORL1, WWC1, and ELAVL4 and identifies novel candidate genes for late-onset Alzheimer's disease Naj, Adam C.
2009
5 4S p. P150-P151
artikel
801 Genome-wide screening for novel Alzheimer's disease genes: What have we found? Tanzi, Rudolph
2009
5 4S p. P147
artikel
802 Genome-wide studies of Alzheimer's disease: The bigger the better Williams, Julie
2009
5 4S p. P165
artikel
803 Glial fibrillary acidic protein and protein S-100B: Different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer' s disease and Creutzfeldt-Jakob disease Jesse, Sarah
2009
5 4S p. P505-P506
artikel
804 Global prevalence of dementia Ferri, Cleusa P.
2009
5 4S p. P118
artikel
805 Glutamatergic receptors in the neocortex of Vascular Dementia (VaD) and Mixed Dementia (MIX) Mohamed, Nur-Ezan
2009
5 4S p. P491
artikel
806 Glycemic control and risk of dementia in a large cohort of elderly patients with type 2 diabetes Whitmer, Rachel
2009
5 4S p. P123
artikel
807 Glycogen synthase kinase-3 negatively regulates the level of protein phosphatase-2A catalytic subunit through camp-responsive element-binding protein-dependent pathway Yang-Yang, Yin
2009
5 4S p. P395
artikel
808 Glycogen synthase kinase-3 regulates the activity of protein phosphatase 2A by post-translational phosphorylation and methylation Yao, Xiuqing
2009
5 4S p. P474
artikel
809 Good days and bad days in dementia: A qualitative analysis of variability in symptom expression Rockwood, Kenneth
2009
5 4S p. P233-P234
artikel
810 Good Protein, Bad Protein: A New Aβ Variant Can Be Both Tagliavini, Fabrizio
2009
5 4S p. e1-e2
artikel
811 G protein coupling of galanin, muscarinic and cannabinoid receptors in areas related to the control of memory and cognitive functions of Alzheimer patients Manuel, Ivan
2009
5 4S p. P492
artikel
812 Graph Theory Metrics Of Resting State Networks In MCI And AD Lim, Kelvin O.
2009
5 4S p. e11
artikel
813 GRB-associated binding protein 2 (GAB2) interacts with APOE to alter risk of late-onset Alzheimer's disease Beecham, Gary W.
2009
5 4S p. P111
artikel
814 Grey matter volume loss in medial and anterior temporal regions may explain excessive lexical semantic decline in MCI APOE e4 carriers Biundo, Roberta
2009
5 4S p. P362
artikel
815 GSI-953 is a potent APP-selective gamma-secretase inhibitor for the treatment of Alzheimer's disease Jacobsen, Steven
2009
5 4S p. P139
artikel
816 hAPP-SL x hTau crossbreds: A mouse model combining two major Alzheimer hallmarks Mitrovic, Martina
2009
5 4S p. P444
artikel
817 Have we sufficient insights to reconsider procaine as a potent preventive molecule in brain aging? Ileana, Turcu
2009
5 4S p. P339-P340
artikel
818 [3H]DAA1106 binding to hippocampal peripheral benzodiazepine receptors in kainic acid-treated Tg2576 and C57BL6 mice Lu, Yifeng
2009
5 4S p. P180-P181
artikel
819 Head size, age and gender adjustment in MRI studies: A necessary nuisance? Barnes, Josephine
2009
5 4S p. P102-P103
artikel
820 Health-economic benefits of memantine treatment: Translating symptomatic effects into cost savings Wirth, Yvonne
2009
5 4S p. P407
artikel
821 Healthy brain aging process demonstrated stable cognitive performances: The osaki-tajiri project Kasuya, Masashi
2009
5 4S p. P454-P455
artikel
822 Healthy Diet at Midlife and the Risk of Late-Life Dementia and Alzheimer's Disease: A Population-based CAIDE Study Eskelinen, Marjo H.
2009
5 4S p. P284
artikel
823 Help and resources for caregivers who assist persons with alzheimer's disease Vista, Marco
2009
5 4S p. P231-P232
artikel
824 Hereditary diffuse leukoencephalopathy with axonal spheroids Wszolek, Zbigniew K.
2009
5 4S p. P166
artikel
825 High dementia incidence in the oldest old, especially in centenarians: Results from The 90+ Study Corrada, Maria M.
2009
5 4S p. P106
artikel
826 Higher blood glucose is associated with dementia among Chinese elderly independent of vascular risk factors and white matter hyperintensity volume: findings from SCOBHI Mortimer, James
2009
5 4S p. P379
artikel
827 High membrane cholesterol enlarges early endosomes and increases clathrin-dependant APP endocytosis and Abeta production Cossec, Jack-Christophe
2009
5 4S p. P301-P302
artikel
828 High plasma Aβ40 levels are associated with incident Cognitive Impairment not Demented (CIND) and dementia cases in persons of Mexican ancestry (SALSA study) Graff-Radford, Neill R.
2009
5 4S p. P380
artikel
829 High prevalence of dementia in relatively young Latin American populations: diagnostic challenges, possible solutions and opportunities Maestre, Gladys E.
2009
5 4S p. P117
artikel
830 High testosterone coupled with low oestrogen significantly inpaired cognition in aged males Young-Martin, Lauriann E.
2009
5 4S p. P175
artikel
831 Hip fracture risk and subsequent mortality among Alzheimer's disease patients in the United Kingdom, 1988-2007 Baker, Nicole L.
2009
5 4S p. P377
artikel
832 Hippocampal correlates of pain in healthy elderly adults: a pilot study Zimmerman, Molly E.
2009
5 4S p. P219
artikel
833 Hippocampal correlates of pain in healthy elderly adults: A pilot study Zimmerman, Molly E.
2009
5 4S p. P57-P58
artikel
834 Hippocampal glucose metabolism predicts cognitive decline and correlates to disease progression in the ADNI population Matthews, Dawn C.
2009
5 4S p. P127
artikel
835 Hippocampal sclerosis (HpScl) in the elderly with dementia: Clinical, genetic and pathologic findings Pao, Winnie
2009
5 4S p. P188-P189
artikel
836 Hippocampal subfields are superior to total hippocampal volume for the prediction of memory function and decline: A preliminary study Mueller, Susanne
2009
5 4S p. P102
artikel
837 Hippocampal volume and depressive symptoms: a population-based neuroimaging study Geda, Yonas E.
2009
5 4S p. P220
artikel
838 Hippocampal volume and depressive symptoms: A population-based neuroimaging study Geda, Yonas E.
2009
5 4S p. P59
artikel
839 Hippocampal volume loss is associated with increased A-beta levels in the precuneus in mild cognitive impairment Furst, Ansgar J.
2009
5 4S p. P372-P373
artikel
840 Hippocampal volume loss is associated with increased A-beta levels in the precuneus in mild cognitive impairment Furst, Ansgar J.
2009
5 4S p. P35-P36
artikel
841 Histone acetylation enhances neurotrophin expression and synaptic plasticity in aging brain XIE, Cui-Wei
2009
5 4S p. P388
artikel
842 1H MRS and hippocampal volumes predict risk of dementia in a population-based cohort: The mayo clinic study of aging Kantarci, Kejal
2009
5 4S p. P354-P355
artikel
843 Homocysteine, holotranscobalamin and risk of Alzheimer's disease: A longitudinal population-based study Hooshmand, Babak
2009
5 4S p. P387
artikel
844 Homocysteine metabolism and CSF markers for Alzheimer's disease Popp, Julius
2009
5 4S p. P500
artikel
845 Homozygous APP mutations and Alzheimer's disease Mori, Hiroshi
2009
5 4S p. P170
artikel
846 Hormone therapy use and risk factors for Alzheimer's disease: Data from the Wisconsin Registry for Alzheimer's Prevention Gleason, Carey E.
2009
5 4S p. P333
artikel
847 How caregivers provide for the health care of residents with dementia in assisted living facilities Sharpp, Tara J.
2009
5 4S p. P235
artikel
848 How does the Canadian general public view moderate Alzheimer's disease? determination of health utility scores Tarride, Jean-Eric
2009
5 4S p. P238
artikel
849 How many tests are required for diagnosis of memory impairment? Ozge, Aynur
2009
5 4S p. P452-P453
artikel
850 How person-centered caregivers interact with residents with dementia in an assisted living facility Sharpp, Tara
2009
5 4S p. P140
artikel
851 How the morphology of brain sulci may help in detecting early AD? Fouquet, Marine
2009
5 4S p. P371
artikel
852 How the morphology of brain sulci may help in detecting early Alzheimer's disease Fouquet, Marine
2009
5 4S p. P32-P33
artikel
853 How to define the cognitive impairment in Mild Cognitive Impairment: Comparison of different neuropsychological classification methods using data from the Sydney Memory and Ageing Study Kochan, Nicole
2009
5 4S p. P131
artikel
854 How well does ApoE-ϵ4 predict Alzheimer's disease in persons with mild cognitive impairment? Elias-Sonnenschein, Lyzel S.
2009
5 4S p. P288
artikel
855 H3 receptor antagonism increases methylhistamine levels in the cerebrospinal fluid of dogs and healthy human volunteers Soares, Holly
2009
5 4S p. P254-P255
artikel
856 Human amyloid and FDG PET imaging with a novel dedicated Neuropet scanner Worstell, William
2009
5 4S p. P55
artikel
857 Human amyloid and FDG PET imaging with a novel dedicated neuropet scanner Worstell, William
2009
5 4S p. P217
artikel
858 Human glial and neuronal in vitro models of Alzheimer's disease: Effects of immunomodulators on Ab-phagocytosis and neurodegeneration Hjorth, Erik
2009
5 4S p. P176-P177
artikel
859 Human Immunoglobulin Heavy Chains Have Novel Fibril-binding And Anti-amyloidogenic Activity Dessain, Scott
2009
5 4S p. e20
artikel
860 Human phase-1 Multiple Ascending Dose (MAD) study - safety, tolerability and pharmacokinetics of SUVN-502, a 5-HT6 receptor antagonist Nirogi, Ramakrishna
2009
5 4S p. P250-P251
artikel
861 Human Photosynthesis And Its Impact In Alzheimer'S And Other Neurodegenerative Diseases Solis-Herrera, Arturo
2009
5 4S p. e26
artikel
862 Hydrogen sulfide: A novel neuroprotectant in the neurodegenerative diseases Hu, Lifang
2009
5 4S p. P64
artikel
863 Hydrogen sulfide, a novel neuroprotectant in the neurodegenerative diseases Hu, Lifang
2009
5 4S p. P420
artikel
864 27-hydroxycholestrol as the missing link between circulating cholesterol and AD-like pathology Ghribi, Othman
2009
5 4S p. P180
artikel
865 Hydroxynonenal generated crosslinking fluorophores accumulate in Alzheimer's disease Shenk, Justin C.
2009
5 4S p. P315
artikel
866 Hyperinsulinemia, defined as low adiponectin or type 2 diabetes in the elderly, is related with higher late-onset Alzheimer's disease risk Luchsinger, Jose A.
2009
5 4S p. P386
artikel
867 Hypertension as a treatment target for prevention of dementia: Considerations for trial design based on experience of the SCOPE and PRoFESS cognitive substudies Saxby, Brian K.
2009
5 4S p. P394-P395
artikel
868 Hypertension as a treatment target for prevention of dementia: Effects of candesartan on cognitive decline in older hypertensives in the SCOPE substudy, and comparison to normotensive controls Saxby, Brian K.
2009
5 4S p. P457
artikel
869 ICAD Scientific Program Committee 2009
5 4S p. A2
artikel
870 Idealization of marriage as a distress buffer among spouses of Alzheimer patients O'Rourke, Norm
2009
5 4S p. P231
artikel
871 Identification, characterization, and comparison of amino-terminally truncated Aβ42 peptides in Alzheimer's disease brain tissue and in plasma from Alzheimer's patients receiving solanezumab immunotherapy treatment DeMattos, Ronald B.
2009
5 4S p. P156-P157
artikel
872 Identification of amylospheroid-binding proteins from mature neurons as a molecular target of neurotoxicity induced by nonfibrillar AB assemblies Kitamura, Yasuki
2009
5 4S p. P222-P223
artikel
873 Identification of an oral pharmaceutical known to penetrate the CNS that inhibits the formation of Aβ oligomers in vitro Moore, Susan
2009
5 4S p. P431
artikel
874 Identification of HPA axis dysfunction in ApoE targeted replacement mice Warwick, Helen K.
2009
5 4S p. P308
artikel
875 Identification of prodromal Alzheimer's with serial neuropsychological tests Orgogozo, Jean-Marc
2009
5 4S p. P160
artikel
876 Identification of protein changes in CSF from Alzheimer subjects using global profiling analysis Waring, Jeffrey F.
2009
5 4S p. P345
artikel
877 Identification of serum biomarker candidates for Alzheimer's disease Mueller, Claudius
2009
5 4S p. P344-P345
artikel
878 Identification of three novel progranulin mutations in a series of patients affected by sporadic and familial frontotemporal lobar degeneration Chiara Cupidi,
2009
5 4S p. P406
artikel
879 Identifying a hidden problem—dementia—in elderly people living in old-age homes Khan, Mudassir A.
2009
5 4S p. P390
artikel
880 Imaging amyloid: Now that we can see it, what does it all mean? Klunk, William E.
2009
5 4S p. P68
artikel
881 Imaging CDK5 kinase activity with a small, genetically encodable fluorescent sensor Zondlo, Neal J.
2009
5 4S p. P476
artikel
882 Imaging of amyloid plaques and cerebral glucose metabolism in amnestic mild cognitive impairment Choo, Il Han
2009
5 4S p. P198
artikel
883 Imaging of amyloid plaques and cerebral glucose metabolism in amnestic mild cognitive impairment Choo, Il Han
2009
5 4S p. P22
artikel
884 Imaging of dementia with Lewy bodies O'Brien, John T.
2009
5 4S p. P73
artikel
885 Imaging of vascular cognitive impairment Black, Sandra E.
2009
5 4S p. P72-P73
artikel
886 Immune-based therapy for Alzheimer's disease is associated with elevated levels of IL-10 in the brain Koronyo-Hamaoui, Maya
2009
5 4S p. P328
artikel
887 Immune response induced by Aβ42-mimotope displaying M13 phage particles Kitamoto, Sho
2009
5 4S p. P423-P424
artikel
888 Immune system reconstitution reduces Aβ/β-amyloid pathology in PSAPP mice Tan, Jun
2009
5 4S p. P113
artikel
889 Immunization of dogs with C-terminal sequences of beta-amyloid protein is safe and depletes the protein from the blood Pesini, Pedro
2009
5 4S p. P419
artikel
890 Immunohistochemical analyses of GM1-ganglioside-bound amyloid β-protein in various aged cynomolgus monkey brains Kimura, Nobuyuki
2009
5 4S p. P297
artikel
891 Immunotherapy targeting abnormal protein conformation Wisniewski, Thomas
2009
5 4S p. P113
artikel
892 Immunotherapy targeting Alzheimer's phospho-tau epitope within the microtubule binding region of tau clears pathological tau and prevents functional decline in a mouse model of tauopathy Krishnamurthy, Pavan K.
2009
5 4S p. P112
artikel
893 Immunotherapy Targeting Pathologically Phosphorylated Tau in a Tauopathy Mouse Model Boimel, Moran
2009
5 4S p. e6
artikel
894 Impact of apoE genotype on circulating IL-18 and amyloid beta levels in Alzheimer's disease Reale, Marcella
2009
5 4S p. P306
artikel
895 Impact of cognitive impairment on screening mammography use in older U.S. women Mehta, Kala M.
2009
5 4S p. P237
artikel
896 Impact Of Statin Blood-brain Barrier Permeability On Test Performance In Asymptomatic Middle-aged Adults At Risk For AD: The WRAP Cohort Carlsson, Cynthia M.
2009
5 4S p. e9
artikel
897 Impairment Of Adolescent Hippocampal Plasticity In Mouse Models For Alzheimer's Disease Precedes Disease Phenotype Hartl, Daniela
2009
5 4S p. e10
artikel
898 Implications of new AD diagnostic criteria on pharmaceutical research Feldmann, Howard
2009
5 4S p. P99
artikel
899 Improved characterization of cognitive performance profiles within measurement sessions Steinerman, Joshua R.
2009
5 4S p. P374
artikel
900 Improvement of psychological and emotional well being in Alzheimer caregivers after a psychoeducational intervention Facal, David
2009
5 4S p. P409-P410
artikel
901 Incidence of dementia and rate of conversion of CDR=0.5 cases, in a cohort of elderly living in Sao Paulo, Brazil Ramos, Luiz R.
2009
5 4S p. P384
artikel
902 Increased BACE1 activity in CSF of patients with an Alzheimer biomarker profile Mulder, Sandra D.
2009
5 4S p. P343
artikel
903 Increased [11C]PET And [18F]FDDNP Binding Are Selectively Associated With Memory Impairment van Berckel, Bart
2009
5 4S p. e32
artikel
904 Increased expression of sodium-calcium exchanger 3 (NCX3) in amyloid-beta positive synaptosomes Sokolow, Sophie
2009
5 4S p. P299
artikel
905 Increased levels of CSF tau and phosphorylated tau (p-tau 181) correlate with memory deficits in mild cognitive impairment Kanemaru, Kazutomi
2009
5 4S p. P343
artikel
906 Increased right insular glucose metabolism in vascular dementia after comprehensive rehabilitation approach Tanaka, Naofumi
2009
5 4S p. P412
artikel
907 Increased risk of serious comorbidities in a cohort of AD patients compared to a similar non-AD cohort Malone, Daniel
2009
5 4S p. P283
artikel
908 Increased sensitivity and specificity of a neurocognitive screening battery by incorporating measures of reaction tme and reaction time variability Gualtieri, Thomas
2009
5 4S p. P364-P365
artikel
909 Increase health burden in the association of depressive symptoms in the elderly Ferreira, Francine N.
2009
5 4S p. P66-P67
artikel
910 Increase health burden in the association of depressive symptoms in the elderly Ferreira, Francine N.
2009
5 4S p. P329-P330
artikel
911 Indian perspectives on assessment, treatment, and family roles Krishnamoorthy, Ennapadam S.
2009
5 4S p. P118
artikel
912 Induction of calcineurin activity and signaling by oligomeric amyloid-beta isolated from Alzheimer brains Reese, Lindsay C.
2009
5 4S p. P496
artikel
913 Induction of mutant tau expression in aged rTg4510 mice does not rapidly induce tauopathy Cannon, Ashley D.
2009
5 4S p. P400-P401
artikel
914 Induction of rapid and robust anti-Aβ antibody production by reactivation of pre-existing memory Th cells generated from conventional vaccines Ghochikyan, Anahit
2009
5 4S p. P112-P113
artikel
915 Inflammatory effects of Aβ alloforms and conformations on human astrocytes Shepherd, Claire E.
2009
5 4S p. P482-P483
artikel
916 Influence of GGA protein modifications on BACE interaction von Einem, Bjoern
2009
5 4S p. P302-P303
artikel
917 Influence of iron genes and gender on brain iron and cognition Bartzokis, George
2009
5 4S p. P211
artikel
918 Influence of iron genes and gender on brain iron and cognition Bartzokis, George
2009
5 4S p. P41
artikel
919 Influence of presenilin mutation on tau pathology in a novel Alzheimer's disease mouse model Boutajangout, Allal
2009
5 4S p. P445-P446
artikel
920 Influence of the apolipoprotein E type 4 allele on cerebral amyloid deposition and glucose metabolism in cognitively normal elderly: PIB-PET and FDG-PET study Choo, IlL Han
2009
5 4S p. P210-P211
artikel
921 Influence of the apolipoprotein E type 4 allele on cerebral amyloid deposition and glucose metabolism in cognitively normal elderly: PIB-PET and FDG-PET study Choo, Il Han
2009
5 4S p. P41
artikel
922 Influence of trans-fatty acid supplementation on the SAPPα-to-SAPPβ ratio in SH-SY5Y cell cultures Murri, Samuel
2009
5 4S p. P226
artikel
923 Informal caregiving for older adults with dementia: Economic and health implications Langa, Kenneth M.
2009
5 4S p. P119
artikel
924 Inhibiting effect of docosahexaenoic acid on the amyloid beta peptide fibrillation Hashimoto, Michio
2009
5 4S p. P419-P420
artikel
925 Inhibition of glutaminyl cyclase reduces amyloid pathology in transgenic animals Rossner, Steffen
2009
5 4S p. P75
artikel
926 Inhibition of phospholipase A2 modulates glycogen synthase kinase (GSK) activity and Tau phosphorylation in primary cultures of cortical and hippocampal neurons De Paula, Vanessa J.R.
2009
5 4S p. P401
artikel
927 Inhibition of phospholipase A2 modulates glycogen synthase kinase (GSK) activity and Tau phosphorylation in primary cultures of cortical and hippocampal neurons de Paula, Vanessa J.R.
2009
5 4S p. P46
artikel
928 Inhibition of plasminogen activator activity may be critical in the loss of cognitive function and amyloid-beta accumulation in Alzheimer's disease brain Seeds, Nicholas
2009
5 4S p. P302
artikel
929 Inhibitors Of Catalase-Amyloid Interactions Protect Cells From Oxidative Stress And Toxicity Induced By Aggregated Alzheimer's-Related beta-Amyloid Peptides Habib, Lila K.
2009
5 4S p. e22-e23
artikel
930 Innate immune pathology in Alzheimer's disease Golenbock, Douglas T.
2009
5 4S p. P71
artikel
931 iNOS gene deficiency modifies amyloid β deposition, cognitive performance and hippocampal long-term potentiation in an APP transgenic mouse model Kummer, Markus P.
2009
5 4S p. P89
artikel
932 In pretangle cells truncation at Asp-421 along the C-terminus of tau protein appears to precede that of the Glu-391 in Alzheimer's disease Luna-Muñoz, José
2009
5 4S p. P403
artikel
933 Insulin metabolism and the risk of Alzheimer's disease: The Rotterdam Study Schrijvers, Elisabeth
2009
5 4S p. P383-P384
artikel
934 Insulin resistance and Alzheimer's disease: Untangling the web Craft, Suzanne
2009
5 4S p. P142
artikel
935 Integrating MR techniques to study Alzheimer's disease Barkhof, Frederik
2009
5 4S p. P3
artikel
936 Integration of Cognitive Impairments with White Matter Ischemic Changes into 12 Cell Diagnostic Matrix System: findings from the CREDOS Study Kim, Seong Yoon
2009
5 4S p. P289-P290
artikel
937 Intensity of long-term physical activity and later life cognition in postmenopausal women Tierney, Mary C.
2009
5 4S p. P378
artikel
938 Interaction between C-Reactive protein level and APOE genotype in predicting rate of progression in Alzheimer's disease: The Cache County dementia progression study Tschanz, JoAnn T.
2009
5 4S p. P192
artikel
939 Interaction of Engulfment Adaptor Protein (GULP) and Amyloid Precursor Protein (APP) decreases Aβ40/42 secretion Beyer, Anja-Silke
2009
5 4S p. P300-P301
artikel
940 Interactions between PKR (Double Stranded RNA-Dependent Protein Kinase) and Gsk3β (Glycogen Synthase Kinase 3β) in Alzheimer’s disease (AD) Bose, Anindita
2009
5 4S p. P136
artikel
941 Interactions between tau phosphatases and tau kinases in formation of tau hyperphosphorylation in Alzheimer's disease Pei, Jin Jing
2009
5 4S p. P93-P94
artikel
942 Interest of CSF markers in positive diagnosis of Alzheimer's disease in routine clinical practice Gabelle, Audrey
2009
5 4S p. P353
artikel
943 Intergenerational Studies of Dementia Risk Wolf, Philip A.
2009
5 4S p. P92
artikel
944 Internalization of Abeta amyloid peptides in neuronal cells depending of their sequence and their structural assembly Perrone, Lorena
2009
5 4S p. P311-P312
artikel
945 Internalization of the amyloid beta (Aβ) peptide may result in binding to the regulatory region of the APP gene promoter Bailey, Jason A.
2009
5 4S p. P315-P316
artikel
946 Interrelation between gray and white matter alterations in Alzheimer's disease and frontotemporal dementia Zhang, Yu
2009
5 4S p. P197
artikel
947 Interrelation between gray and white matter alterations in Alzheimer's Disease and Frontotemporal Dementia Zhang, Yu
2009
5 4S p. P20
artikel
948 Intrabodies against Aβ oligomers Meli, Giovanni
2009
5 4S p. P303-P304
artikel
949 Intrabody against immature nicastrin disrupts the proper folding and the glycosyl maturation of the extracellular domain of nicastrin Takatori, Sho
2009
5 4S p. P317
artikel
950 Intracellular trafficking of TDP-43 and its potential role in disease Buratti, Emanuele
2009
5 4S p. P166
artikel
951 Intracranial Atherosclerosis as a contributing factor to Alzheimer's disease Dementia Kokjohn, Tyler A.
2009
5 4S p. P293
artikel
952 Intranasal deferoxamine improves radial arm water maze performance in P301L tau transgenic mice Fine, Jared M.
2009
5 4S p. P319
artikel
953 Intraneuronal Aβ accumulation in Alzheimer's disease Poduslo, Joseph F.
2009
5 4S p. P116
artikel
954 Intraneuronal Abeta triggers neurodegeneration: New evidence from mouse models Bayer, Thomas A.
2009
5 4S p. P75
artikel
955 Intravenous immunoglobulin (IVIg) Gammagard liquid contains anti-RAGE IgG and sLRP Weber, Alfred
2009
5 4S p. P416
artikel
956 Intrinsically disordered protein tau with unsheltered microtubule-binding domain become mis-disordered: Implications for neurofibrillary degeneration Skrabana, Rostislav
2009
5 4S p. P401
artikel
957 Investigating psychosis candidate genes in Alzheimer's disease with psychosis using genome-wide association studies Sims, Rebecca
2009
5 4S p. P466-P467
artikel
958 Investigation of diurnal fluctuations in tau levels in CSF from mild-to-moderate Alzheimer's patients Li, Jinhe
2009
5 4S p. P134
artikel
959 Investigation of low molecular weight D-enantiomeric peptides for diagnosis and therapy of Alzheimer's disease Bartnik, Dirk
2009
5 4S p. P426
artikel
960 Investigation of the critical amino acids in the BACE1 binding site that interact with small molecule inhibitors using a novel radioligand and X-ray crystallography Hirst, Warren D.
2009
5 4S p. P429
artikel
961 In vivo amyloid deposition and neuropathological findings after humanized amyloid β-specific monoclonal antibodies therapy in a patient with Alzheimer's disease Lopez, Oscar L.
2009
5 4S p. P64-P65
artikel
962 In vivo amyloid plaque detection using contrast-enhanced magnetic resonance microscopy in transgenic mice Petiet, Alexandra
2009
5 4S p. P8
artikel
963 In vivo amyloid plaque detection using contrast-enhanced magnetic resonance microscopy in transgenic mice Petiet, Alexandra
2009
5 4S p. P208-P209
artikel
964 In vivo analysis of methylene blue and kinase inhibitors in a Tau transgenic zebrafish model Haass, Christian
2009
5 4S p. P82
artikel
965 In vivo analysis of the effect of mutant PS1 on dendritic spines in the somatosensory cortex of transgenic mice Jung, Christian K.E.
2009
5 4S p. P317-P318
artikel
966 In vivo efficacy of BACE-1 inhibitor CTS21166 (ASP1702) in rat CNS compartments Yu, Jeremy
2009
5 4S p. P430-P431
artikel
967 In vivo optical and PET detections of fibrillar tau lesions in a mouse model of tauopathies Maruyama, Masahiro
2009
5 4S p. P209-P210
artikel
968 In vivo optical and PET detections of fibrillar tau lesions in a mouse model of tauopathies Maruyama, Masahiro
2009
5 4S p. P9
artikel
969 Involvement of GSK3 in the homocysteine-dependent modulation of the Alzheimer-like phenotype in vivo Pratico, Domenico
2009
5 4S p. P444
artikel
970 Involvement of LRP1 and RAGE in the transport of β-amyloid (Aβ) peptide across the blood-brain barrier: Use of an in vitro model Candela, Pietra
2009
5 4S p. P174-P175
artikel
971 Involvement of metals in Aβ aggregation in Alzheimer's disease brain and lens using X-ray Fluorescent Microscopy (XRFM) and Quasi-Elastic Light Scattering (QLS) Goldstein, Lee E.
2009
5 4S p. P489
artikel
972 Involvement of the kynurenine pathway in Alzheimer's disease Guillemin, Gilles J.
2009
5 4S p. P400
artikel
973 Involvement of the regulation of X-linked inhibitor of apoptosis protein by GSK3 Kato, Kiyoko
2009
5 4S p. e26
artikel
974 IRBs' concerns about DNA banking: The CSP #546 experience Love, Susan B.
2009
5 4S p. P460
artikel
975 Iron/Copper metabolism: Candidate genes and endophenotypes interplay in Alzheimer's disease Crespo, Ângela C.
2009
5 4S p. P466
artikel
976 Iron-induced oxidative stress in primary culture of resting and activated astrocytes Macco, Romina
2009
5 4S p. P314-P315
artikel
977 Iron regulatory protein 2 is involved in brain copper homeostasis Mueller, Claudius
2009
5 4S p. P486
artikel
978 Is cognitive-emotion dysfunction a diagnostic tool for early Alzheimer's patients? Snoussi, Molka
2009
5 4S p. P450-P451
artikel
979 7-Isopentenyloxycoumarin as a novel neuroprotective agent Epifano, Francesco
2009
5 4S p. P321
artikel
980 Italian presenilin 2 mutation (R71W) in early-onset dementia with relevant behavioural disturbances Piscopo, Paola
2009
5 4S p. P467
artikel
981 Item analysis of adas-cog and cdr system cognitive measures in ad patients on stable treatment with anticholinesterases Edgar, Chris
2009
5 4S p. P246-P247
artikel
982 Joint Effect Of Hypertension And Apoe Genotype On CSF Biomarkers For Alzheimer's Disease Kester, Maartje I.
2009
5 4S p. e17
artikel
983 Key role of inflammation in Alzheimer pathology Fernandez, Ana M.
2009
5 4S p. P478
artikel
984 Keyword Index 2009
5 4S p. P543-P552
artikel
985 Kinetics of dendritic structural plasticity in the living brain of an Alzheimer's disease mouse model acquired with two photon microscopy Burgold, Steffen
2009
5 4S p. P439
artikel
986 KLVFF-surface-modified Protein Microspheres For Potential Diagnostics And Therapeutics In Alzheimer's Disease (AD) Richman, Michal
2009
5 4S p. e7
artikel
987 KMS88009 and KMS88016 as small molecule inhibitors for in vivo Aβ fibril formation Kim, YoungSoo
2009
5 4S p. P421
artikel
988 Knockdown I2 PP-2A attenuates tau hyperphosphorylation and the underlying mechanisms Hairong, Shi
2009
5 4S p. P322
artikel
989 Knowledge and level of information on Alzheimer's disease in the French population: The effect of socioeconomic status and proximity to the disease Le Corre, Stéphanie Pin
2009
5 4S p. P89-P90
artikel
990 Knowledge and opinions regarding proxy consent for participation in research on Alzheimer's disease: The eppicore study Bravo, Gina
2009
5 4S p. P234-P235
artikel
991 Knowledge-based Discrimination In Alzheimer'S Disease Duchesne, Simon
2009
5 4S p. e20
artikel
992 Korean version of Mini-Mental State Examination and Clinical Dementia Rating Scale Sum of Boxes scores in staging the dementia Kang, Hee Jin
2009
5 4S p. P292
artikel
993 Lack of amyloid precursor proteins APP and APLP2 in ES cell-derived neurons leads to defective synaptic transmission Bibel, Miriam
2009
5 4S p. P69-P70
artikel
994 Larger head circumference and greater education provide protection against incident dementia independent of the severity of Alzheimer pathology: The Nun Study Mortimer, James A.
2009
5 4S p. P379
artikel
995 Late-life body mass index and waist circumference decrease progressively in amnestic mild cognitive impairment and Alzheimer's disease Chu, Leung-Wing
2009
5 4S p. P131
artikel
996 Lecithin: Cholesterol Acyltransferase (LCAT) is required for normal brain apoE metabolism in mice Hirsch-Reinshagen, Veronica
2009
5 4S p. P305
artikel
997 Left anterior parahippocampal gray matter volume is inversely associated with APOE genotypic risk in healthy seniors: Tensor-based morphometry data Browndyke, Jeffrey N.
2009
5 4S p. P41-P42
artikel
998 Left anterior parahippocampal gray matter volume is inversely associated with APOE genotypic risk in healthy seniors: tensor-based morphometry data Browndyke, Jeffrey N.
2009
5 4S p. P211-P212
artikel
999 Leptin and adiponectin in plasma and CSF from Alzheimer's patients and normal controls Une, Kaori
2009
5 4S p. P346
artikel
1000 Lexical access in MCI: A study on the tip-of-the-tongue events Juncos-Rabadán, Onesimo
2009
5 4S p. P377
artikel
                             1764 gevonden resultaten
 
   volgende >>
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland